In the latest close session, Archrock Inc. (AROC - Free Report) was down 5.86% at $36.14. The stock fell short of the S&P 500, which registered a gain of 0.05% for the day. Meanwhile, the Dow experienced a rise of 0.46%, and the technology-dominated Nasdaq saw a decrease of 0.64%.
The stock of natural gas compression services business has fallen by 7.27% in the past month, lagging the Oils-Energy sector's gain of 6.52% and the S&P 500's gain of 0.61%.
The upcoming earnings release of Archrock Inc. will be of great interest to investors. The company's earnings report is expected on August 4, 2026. The company's earnings per share (EPS) are projected to be $0.46, reflecting a 17.95% increase from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $390.4 million, up 1.89% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.9 per share and a revenue of $1.55 billion, indicating changes of 0% and +4.19%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Archrock Inc. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Archrock Inc. boasts a Zacks Rank of #3 (Hold).
From a valuation perspective, Archrock Inc. is currently exchanging hands at a Forward P/E ratio of 20.17. This signifies a discount in comparison to the average Forward P/E of 24.8 for its industry.
We can additionally observe that AROC currently boasts a PEG ratio of 1.68. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Oil and Gas - Field Services was holding an average PEG ratio of 1.68 at yesterday's closing price.
The Oil and Gas - Field Services industry is part of the Oils-Energy sector. This group has a Zacks Industry Rank of 95, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
HSBC zahájila pokrytí SpaceX s doporučením Hold a cílovou cenou 115 USD, což podle ní znamená jen malý prostor pro růst. Banka říká, že „Musk premium“ je už v ceně.
Investors betting on SpaceX SPCX shares are buying into more than just reusable orbital rockets and a global satellite internet network – they are purchasing a ticket to the visionary leadership of Elon Musk.
However, according to a recent analysis from HSBC, that celebrated “Musk factor” may already be fully priced into the equity.
Analysts at the bank initiated coverage on the aerospace pioneer with a Hold rating and a $115 target price, indicating absence of any meaningful upside from current levels.
Note that SpaceX stock has been in a sharp downtrend in recent weeks. At writing, it’s trading even below its IPO price of $135.
Standard financial formulas used for traditional conglomerates, SPACs, or biotech firms simply fail to reflect how the market rates elite founders who reshape global industries.
To capture this reality, HSBC departed from classic metrics and built a custom sum-of-the-parts model featuring a 2x “innovation premium”.
The benchmark for this multiplier was drawn directly from Tesla’s first decade on public markets, leveraging Musk’s established track record in disruptive manufacturing and commercial deployment.
The bank noted that while analysts often apply holding company discounts, special founder premiums are warranted when leaders consistently upend whole sectors.
Yet even with this generous multiplier factored in, HSBC concludes that current market prices leave very little room for short-term upside on SPCX shares.
The core takeaway from HSBC’s base-case framework is that today’s market valuation already anticipates seamless execution across SpaceX’s main business pillars.
Investors have fully embedded expectations for Starlink's expanding global subscriber footprint, high-frequency Falcon launch manifests, and early-stage spatial artificial intelligence initiatives.
However, the report cautions that for SpaceX shares to breach higher territory, the company must overdeliver; HSBC did outline an optimistic “blue sky” scenario valuation of $293 per share.
But achieving it requires aggressive operational milestones: commercial viability for the next-generation Starship rocket by 2027, doubling overall launch throughput relative to base estimates, extracting significantly higher average revenue per user (ARPU) from Starlink, and securing top-tier software multiples for its internal AI infrastructure.
While long-term bulls point to that $293 optimistic view, short-term realities on the trading floor reflect heightened scrutiny.
SPCX stock has faced headwinds following technical delays around its pivotal 13th Starship test flight and market anxiety over massive insider share unlock periods approaching in August.
While institutional backers continue to view Starship as the key to unlocking exponential payload scale, HSBC’s balanced stance highlights that execution risks cannot be ignored.
Until SpaceX consistently proves out Starship's full orbital reusability and commercial monetization, the stock appears bound to its fundamental trajectory, leaving the famous Musk premium firmly baked into the price for now.
At 6:45 p.m. ET tonight, SpaceX (SPCX -2.85%) gets a third try at its most consequential launch as a public company. Starship Flight 13 has a 90-minute window to lift off from the company's Starbase site in Texas, carrying the first 20 next-generation Starlink V3 satellites.
"Some of the engines didn't start, triggering an automatic launch abort," CEO Elon Musk wrote on X after the first attempt on July 16. SpaceX swapped out engines, and then weather postponed the second try on Thursday.
The stock could use the win. Shares sit at about $112 as of this writing, roughly 1% above their all-time low of $110.85 and well below the $135 price from June's initial public offering (IPO).
Image source: The White House.
What tonight actually decides is the timeline of Starlink's next capacity leap. Each V3 satellite is designed to deliver about 1 terabit per second of downlink capacity, roughly 10 times what the current generation of satellites provides. A full Starship load of about 60 of them would add roughly 60 terabits per second to the network, about 20 times what a Falcon 9 launch delivers today. That capacity is what lets a satellite network sell faster service to more subscribers without congestion. It's the foundation of the company's plan to turn Starlink into a gigabit-speed internet provider.
Today's Change
(
-2.85
%) $
-3.37
Current Price
$
114.87
The satellites can only ride on Starship, though, and Starship has kept them grounded for eight days now. The 20 satellites aboard are a deployment test: They will extend their solar arrays and antennas and attempt to connect with the larger Starlink constellation. Until that demonstration works, the V3 capacity ramp stays theoretical.
A successful flight tonight won't settle the argument over the stock, which still carries a market value near $1.5 trillion against a business that loses money. The next major financial update arrives Aug. 4, when SpaceX is scheduled to report its first quarterly results as a public company. But a clean deployment would show the next generation of the company's biggest product working in space before those numbers land. After six weeks of nearly uninterrupted decline, that would count as the first hard piece of good news this stock has had.
Daniel Sparks and his clients do not have positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Tesla klesla za týden o 18 % po slabších výsledcích ve 2. čtvrtletí, což byl její nejhorší týdenní propad od roku 2022. SpaceX před testem Starship V3 ztratila za pět dní 7,2 %.
Tesla shares plunged 18% during the week to close at $313.03 on Friday, their worst weekly slump since 2022. And SpaceX continued its downward slide, dropping 7.2% over five days to close at $115.07 Friday, its lowest since the company's record IPO last month.
The declines in both stocks wiped away about $130 billion of Musk's wealth, weeks after he'd become the world's first trillionaire. In a post on X on Friday, Musk wrote, "(Former) trillionaire."
Tesla's slump was spurred by weaker-than-expected earnings when the electric vehicle maker reported second-quarter results late Wednesday. The company turned cash flow negative due to a surge in spending on futuristic projects like robotaxis, humanoid robots and a giant chip fab.
"We expect this to pressure free cash flow and delay earnings growth, without providing any near-term shareholder return," wrote analysts at Argus Research, which has a hold rating on the stock, in a report on Friday. "We believe it will be nearly impossible for Tesla to generate any consistency in profit growth in the near-term."
Tesla's stock is now down 30% for the year, by far the worst performer among tech's megacaps.
Read more CNBC tech newsMoonshot AI accessed Nvidia's chips despite Chinese export ban, White House official saysAlphabet and Tesla test Wall Street's patience as AI spending overshadows growthAlphabet earnings takeaways: Q2 revenue beats, GOOGL stock sinks on 2026 capex hikeTesla misses on earnings, as free cash flow turns negative and margins slideMeanwhile, SpaceX's stock has been on a steady downward trajectory over the past month following an initial pop when the company went public. The shares have dropped for four of the past five weeks and are about 43% off their peak close on June 16.
On Friday evening, SpaceX will again attempt the 13th test flight of Starship, the largest rocket ever built or flown. The company plans to fly the new version of the rocket, Starship V3, from its company town and launch facility in Starbase, Texas. The rocket is designed to be fully reusable and is considered crucial for SpaceX's near-term aims to vastly grow its Starlink satellite network.
In a post on X, which is owned by SpaceX, the company said it delayed the test flight planned for Thursday "due to weather." SpaceX previously scrubbed a test flight last week, after the rocket's booster triggered a hold, which "shut down the engines right as they were starting to ignite," a SpaceX employee said during a livestream of the event.
A successful launch of Starship V3, an upgraded version of its roughly 400-foot-tall rocket, would be the first since the company's IPO.
SpaceX plans to use Starship to bring U.S. astronauts back to the Moon's surface, and Musk wants the rocket to eventually run manned missions to Mars.
Musk made a public appearance this week, sitting down for what turned out to be a contentious interview with The Economist.
Zanny Minton Beddoes, editor-in-chief of the publication, asked Musk about his support for "not just the populist right, but the far right, in fact very fringe parties in some countries."
In addition to his financial and vocal support for President Donald Trump, including his work for the second administration, Musk has endorsed Germany's AfD, an extreme anti-immigrant party, as well as the UK's Restore Britain, founded by Rupert Lowe, who also calls to "reverse mass migration."
"It's just normal people!" Musk said in response. He berated Beddoes and "the traditional media" for an "absurd characterization of the far right."
Image Credits:Eric Thayer/Los Angeles Times / Getty Images Waymo is reportedly looking for a way out of its deal with Uber, which has made the Alphabet-owned company’s robotaxis available on the ride-hailing giant’s network in Austin and Atlanta, according to the Financial Times.
Waymo already told Uber that it intends to offer robotaxis on its own app in those markets starting in January 2028 and alongside the existing offering, the ride-hail giant told TechCrunch on Friday. Uber said the contract with Waymo that covers Austin and Atlanta ends in May 2028. The two companies already split in Phoenix earlier this year, as TechCrunch first reported.
Waymo didn’t immediately respond to a request for comment.
This all follows months of rising tensions between Waymo and Uber. Earlier this year, Uber CTO Praveen Neppalli posted a video of what he thought was unsafe and “scary” behavior of a Waymo robotaxi. In May, Uber CEO Dara Khosrowshahi lightly criticized the behavior of Waymo’s robotaxis in school zones and emergency situations during an earnings call, though without naming the company.
Waymo, meanwhile, has wound up opposite Uber in a number of fresh policy fights over robotaxi regulations.
Amazon zavírá své sanfranciské pracoviště AGI v rámci letošních propouštění, ale výzkum frontier modelů pokračuje. Novinka Nova Act zůstává dostupná na AWS.
by Todd Bishop on Jul 24, 2026 at 12:46 pmJuly 24, 2026 at 12:49 pm
GeekWire File Photo Amazon is closing its San Francisco AGI site as part of the layoffs it made this week in its artificial general intelligence organization, but said its frontier model research lab will continue.
A company spokesperson confirmed the news of the site closure, which was first reported by The Information. Amazon’s frontier model research work will carry on under Pieter Abbeel, a UC Berkeley professor who joined Amazon in 2024 when the company licensed the technology and hired the team from Covariant, the robotics startup he co-founded.
The AGI Lab was founded in December 2024 and initially built around several dozen employees Amazon brought in from the startup Adept, including its co-founder and CEO David Luan.
The team grew to about 80 people at its peak, according to The Information, but more than a dozen of the Adept hires have since left, Luan among them. Earlier this week, Amazon confirmed it was cutting an unspecified number of jobs across the broader AGI organization.
Impacted employees will have the chance to explore other roles at Amazon, the spokesperson said, and the company is supporting them through that process.
Nova Act, the browser-agent model and service that came out of the group, remains available on AWS and in use by customers. More broadly, AWS has continued to build out its agentic AI lineup, including Bedrock AgentCore and applications like Kiro, Quick, Continuum and Transform.
The moves come as Amazon invests heavily in helping customers deploy AI, including a $1 billion AWS effort to embed engineers with businesses building AI agents. The initiative reflects an expanded industry focus toward putting agents and models to better use for customers.
Previous Story‘The Odyssey’ isn’t on IMAX 70mm in Seattle — is it worth a journey for the summer’s biggest film?
Boeing uzavřel 1. čtvrtletí s rekordním backlogem 695 miliard USD a tržby meziročně vzrostly o 14 % na 22,217 miliardy USD. FAA navíc 23. července obnovila jeho oprávnění vydávat konečné certifikace pro 737 MAX a 787.
Boeing (NYSE:BA | BA Price Prediction) enters its July 28 Q2 earnings report with a decade of revenue visibility with a market cap that’s less than a quarter of the price of the total order book. With deliveries rising, debt falling, and defense revenue accelerating, Boeing is showing meaningful progress in its turnaround.
Boeing’s Backlog Is 4x Larger Than Its Market Cap Boeing closed Q1 2026 with a record $695 billion backlog and currently sports a market cap of $164.48 billion. First-quarter revenue grew 14% year over year to $22.217 billion, commercial deliveries climbed to 143 aircraft from 130, and management paid down $6.95 billion of debt in the quarter, taking total debt from $54.1 billion to $47.2 billion.
The Defense Boom Is Already Showing Up in Boeing’s Results The FY2027 Department of War budget totals roughly $1.45 trillion, a 42% annual increase with 26% growth in air power funding. Boeing is already scaling into it: Patriot missile seeker production rises to 850 units in 2026 from 650 last year and 400 two years ago.
Defense, Space & Security revenue jumped 21% to $7.599 billion with operating earnings up 50% to $233 million. On July 23, the FAA restored Boeing’s authority to issue final airworthiness certifications for the 737 MAX and 787, removing a multi-year overhang.
Boeing Has a Bigger Order Book Than Lockheed Martin and RTX Combined Lockheed Martin (NYSE:LMT) and RTX Corporation (NYSE:RTX) posted strong quarters, with Lockheed up 10% and RTX up 7%, but their order books are a fraction of Boeing’s. Lockheed reports a $230 billion backlog and RTX $289 billion, versus Boeing’s $695 billion.
Analysts’ consensus price target on $BA sits at $270.08 against the stock’s current share price of $209.23, with 21 buy ratings versus one sell.
The Bottom Line: Boeing’s Turnaround Has Become Measurable Boeing’s Q2 2026 earnings report is due July 28, with the Street modeling a loss of 34 cents per share on $24.05 billion of revenue. The Q1 core loss already narrowed from $0.49 to $0.20, Director Bradley Tilden bought 1,370 shares at $218.50 in May, and prediction markets price the earnings beat at 64% with a crowd that has been 100% correct on prior BA markets. The July 28 earnings report is the next catalyst that could let Boeing’s backlog thesis compound.
Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
Verizon uzavřel s Googlem AI infrastrukturu za více než 1 miliardu USD a čeká další podobné dohody do konce roku. Firma z nich očekává v příštích letech „několik miliard dolarů“ výnosů.
Verizon signed an over $1 billion artificial intelligence (AI) infrastructure deal with Google, and the company expects to sign several similar deals by the end of the year, Verizon CEO Dan Schulman said Friday (July 24) during a second quarter earnings call.
In the recently signed agreement, Verizon dark fiber will be used to connect Google’s data centers. In the other deals that the company expects to announce by year’s end, Verizon will earn “multiple billions of dollars in revenue” over the next several years, Schulman said.
“These are long-duration, high-quality contracted revenue streams from some of the most demanding infrastructure customers in the world,” Schulman said.
“We believe that this is just the beginning,” Schulman added. “The build-out of AI infrastructure across the United States is one of the largest capital cycles of our lifetime.”
Verizon is uniquely positioned to participate in this build-out because it owns an extensive long-haul and metro fiber footprint and it has built the carrier-grade, low-latency, highly resilient transport network that hyperscalers need to connect compute, models and regions, Schulman said.
The company has also begun retrofitting many of its central offices into data centers for inference edgecomputing, and it is already talking with multiple partners who are eager to use these power-ready and permitted locations, he said.
“We are moving quickly to expand our TAM [total addressable market] in the rapidly growing AI infrastructure market,” Schulman said. “The agreements we have signed are the leading edge of a strategy that will become a meaningful, incremental leg of growth for Verizon.”
Verizon announced in a January 2025 press release that it launched a strategy and suite of products and solutions called Verizon AI Connect that is designed to serve hyperscalers, cloud providers and global enterprises by managing AI resource-intensive workloads.
The company said at the time that Google Cloud and Meta were among the early adopters of these solutions.
In a Friday earnings release, Schulman said: “Our core connectivity business is gaining momentum, and with the emergence of AI infrastructure revenue, we are fundamentally reshaping Verizon’s growth trajectory.”
PYMNTS reported Wednesday that during Google parent company Alphabet’s second-quarter earnings call, the company announced that it had raised its 2026 capital spending forecast from the previous $180 billion to $190 billion to the new forecast of $195 billion to $205 billion.
Bristol Myers Squibb má výnos z dividendy 4,1 % a podle odhadů ji letos pokryjí zisk 2,5× a volný cash flow více než dvojnásobně. Rizikem je patentový útes: Eliquis a Opdivo mohou čelit generikům do roku 2028.
When dividend yields start to creep up, it's worth taking a closer look for any potential warning signs. Bristol Myers Squibb (BMY +0.94%) is a leading pharmaceutical company and has been a high-yield dividend stock for some time. Shares have averaged a dividend yield of 3.4% over the past decade.
However, that yield has been abnormally high for most of the past two years. The stock yields 4.1% today, and it's been as high as 6% over the past 24 months. Is the dividend simply too good to be true at this point?
My take is that the dividend is fine right now, but that you'll also need to watch out for potential hurdles as key drugs lose patent exclusivity over the next few years.
Image source: The Motley Fool.
The financials back up Bristol Myers Squibb's juicy dividend for now There's a famous expression that money talks. Examining the financials is the best way to check whether a company can actually afford its dividend. Bristol Myers Squibb pays a quarterly dividend totaling $2.52 per share for the year. Wall Street analysts estimate that it will earn $6.34 per share this year, enough to cover the dividend 2.5 times over.
If you're not satisfied, you can double-check this by looking at free cash flow, since dividends are technically a cash expense. Bristol Myers Squibb has generated $5.83 per share in free cash flow over the past year, covering the dividend more than twice over. From a numbers standpoint, the company can genuinely afford its dividend, and quite easily. The near-term risk of a cut seems pretty low.
Today's Change
(
0.94
%) $
0.58
Current Price
$
62.09
Keep an eye on how the drugmaker navigates a looming patent cliff The coast isn't quite clear, though. Patents for some of Bristol Myers Squibb's top-selling drugs will expire over the next few years. As those patents expire, generics will flood the market at low prices, and sales for those branded drugs will crater. It's a normal part of a drug's lifecycle and happens all the time in the pharmaceutical business.
This situation is called a patent cliff, and Bristol Myers Squibb faces a pretty steep one. Eliquis and Opdivo could both face generic competition by 2028 -- and the two drugs combined for over $6.1 billion in sales last year, roughly half of the company's total revenue. Not all is lost, though: Even after the patents expire, branded sales won't go to zero overnight. Additionally, the company has a strong pipeline, and its growth portfolio of newer drugs is steadily taking the baton.
The market perceives Bristol Myers Squibb as a riskier stock these days, and that's not necessarily wrong. Fortunately, the dividend has lots of breathing room, and there's growth from newer drugs on the way. I could see management scaling back dividend growth, perhaps issuing smaller raises to conserve cash while the company navigates these sensitive years. But barring catastrophic failure, I think you can reasonably trust the stock's 4.1% yield now and in the future.
Skyworks očekává ve 3. fiskálním čtvrtletí tržby 900–950 mil. USD a non-GAAP EPS 1,03 USD uprostřed odhadu. Mobilní tržby mají mezikvartálně klesnout o nízké jednotky procent.
Key Takeaways Skyworks expects Q3 revenues of $900M-$950M and non-GAAP EPS of $1.03 at the midpoint.Mobile revenues may decline by low single digits sequentially, indicating normal seasonal weakness.Broad Markets should rise modestly, reach 43% of sales and grow high single digits year over year. Skyworks Solutions (SWKS - Free Report) is slated to release third-quarter fiscal 2026 results on July 28.
For the third quarter of fiscal 2026, the company expects non-GAAP earnings of $1.03 per share at the midpoint of the projected revenue range of $900-$950 million.
The Zacks Consensus Estimate for earnings has remained steady at $1.03 per share in the past 30 days. The projection indicates a 22.56% decrease from the figure reported in the year-ago quarter.
The consensus mark for third-quarter fiscal 2026 revenues is pegged at $922.08 million, indicating a 4.45% year-over-year decline.
Skyworks’ earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 12.31%.
Let us see how things have shaped up prior to the announcement.
Factors Likely to Have Influenced SWKS’ Q3 PerformanceSWKS’ third-quarter fiscal 2026 performance is expected to have suffered from seasonal weakness in the mobile business. Management anticipates a low single-digit sequential decline in mobile revenues, consistent with normal seasonality, which could weigh on overall results, given mobile’s significant share of total revenues. However, management remains optimistic due to healthy sell-through at key customers, strong execution on new product launches and increasing RF complexity driven by artificial intelligence (AI) workloads.
The company is expected to benefit from its recently secured multigenerational Android design win, which is projected to generate more than $1 billion in revenues through 2030, reinforcing its position in premium AI-enabled smartphones. The quarter is also likely to have benefited from healthy customer demand, book-to-bill above 1, lean channel inventories and resilient demand for premium high-complexity mobile solutions, supporting the company’s revenue performance.
The company’s third-quarter fiscal 2026 performance is expected to benefit from continued strength in broad markets, particularly in WiFi, data center and automotive segments. The company reported nine consecutive quarters of growth in broad markets, with these three engines collectively growing 30% year over year and accounting for nearly two-thirds of the broad markets business. Broad markets are projected to be up modestly sequentially, representing 43% of sales and up high single digits year over year.
SWKS’ ongoing product innovation is set to drive growth. The company introduced new BAW filters targeting early 6G FR3 spectrum and next-generation RF front-end solutions supporting frequencies above 7 gigahertz. SWKS expanded its timing portfolio with new clock buffers for data center, wireless infrastructure and PCIe Gen 7 applications. These innovations position SWKS to capture opportunities in emerging technology cycles, such as 6G and WiFi 8, and to meet the increasing complexity and performance demands of AI-driven workloads.
For the fiscal third quarter of 2026, gross margin is projected to remain flat at approximately 44.5-45.5%, reflecting seasonally lower volume and higher input costs. In the second quarter of fiscal 2026, gross profit was $425 million, translating to a gross margin of 45%, which management said aligned with the midpoint of guidance. However, on a year-over-year basis, gross margin contracted 160 basis points.
What Our Model SaysPer the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is the exact case here.
Skyworks has an Earnings ESP of +0.12% and a Zacks Rank #3 at present. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Other Stocks to ConsiderHere are some companies worth considering, as our model shows that these have the right combination of elements to beat earnings in their upcoming releases.
Amphenol (APH - Free Report) has an Earnings ESP of +1.12% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Amphenol shares have gained 16.5% year to date. Amphenol is scheduled to report its second-quarter 2026 results on July 29.
ASE Technology (ASX - Free Report) has an Earnings ESP of +21.21% and a Zacks Rank #2.
ASE Technology shares have surged 145.1% year to date. ASE Technology is set to report its second-quarter 2026 results on July 30.
Fortive (FTV - Free Report) has an Earnings ESP of +2.82% and a Zacks Rank #2 at present.
Fortive shares have gained 9.8% in the year-to-date period. Fortive is set to report its second-quarter 2026 results on July 29.
Devon Energy zvažuje prodej břidlicových aktiv Eagle Ford a Powder River za více než 4 miliardy USD. Firma je chce odprodat kvůli tlaku investorů na soustředění na Permian Basin.
A pump jack operates at a well site leased by Devon Energy Production Company near Guthrie, Oklahoma September 15, 2015. REUTERS/Nick Oxford - TM3EB9F0WO901 Purchase Licensing Rights, opens new tab
CompaniesJuly 24 (Reuters) - U.S. oil and gas producer Devon Energy (DVN.N), opens new tab is weighing a potential sale of its Eagle Ford and Powder River shale assets that could fetch more than $4 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
The potential divestment comes amid continued investor pressure on Devon to streamline its portfolio and focus on its core Permian Basin operations following its recent merger with Coterra Energy, with some shareholders urging faster asset sales.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
The report said Devon is expected to outline a strategic review of the assets when it reports earnings in early August, though it could still opt to retain the properties and no final decision has been made.
The assets are located in South Texas and Wyoming, respectively, and are considered non-core to Devon's Permian-focused strategy, the report said.
US shale producers have been selling assets to pay down debt following a consolidation wave totaling more than $450 billion in deals since the start of 2023, according to the report.
Devon Energy did not immediately respond to Reuters request for comment.
Reporting by Varun Sahay in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Na Lucid Group byla podána hromadná žaloba kvůli údajným zavádějícím tvrzením o výrobě a dodávkách v období od 25. února 2026 do 13. dubna 2026. Akcie po zprávách v prvních dvou obchodních seancích klesly o 1,13 USD na akcii, tedy o 11,35 %, na 8,83 USD.
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Lucid Group, Inc. ("Lucid" or the "Company") (NASDAQ: LCID) on behalf of investors that purchased or otherwise acquired Lucid Group securities between February 25, 2026 and April 13, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Lucid and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than July 28, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
On Friday April 3, 2026, at the close of the market, Lucid issued in a press release stating that the Company "produced 5,500 vehicles" during the first quarter of 2026, while only "deliver[ing] 3,093 vehicles." The press release further stated that "[d]uring the quarter, deliveries of the Lucid Gravity were disrupted for 29 days due to a supplier quality issue with the second-row seats" and, "[a]s result of this, the [C]ompany's ability to meet customer demand was impacted." That same day, Reuters published an article entitled "Lucid misses first-quarter vehicle delivery estimates on supplier disruptions." According to the article Chief Executive Officer Marc Winterhoff, said "[d]eliveries were particularly hit in February" when the Company "paused to reverse the change and inspect vehicles already produced."
In the first two trading sessions following the news, the price of Lucid shares declined by $1.13 per share, or 11.35%, to close at $8.83 per share on April 7, 2026.
Then, on April 14, 2026, Lucid announced preliminary first quarter 2026 financial results, including revenue in the range of $280 million to $284 million, well below the consensus estimate of $433.8 million according to the complaint, and loss from operations in the range of $985 million to $1.005 billion.
Following this news, the price of Lucid stock fell $0.44 per share, or 4.76%, to close at $8.80 per share on April 14, 2026.
The complaint alleges, among other things, that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (i) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (ii) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (iii) accordingly, the Defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Paramount Skydance souhlasila s pozastavením mega-fúze s Warner Bros. Discovery až na pět dní po rozhodnutí v antimonopolních sporech, nebo nejpozději do 1. června 2027, podle toho, co nastane dříve. Akcie Paramountu po zprávě klesly o 3,3 % a WBD o zhruba 0,7 %.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Paramount Skydance CEO David Ellison is waiting longer to land Warner Bros. Discovery. Gilbert Flores/Variety via Getty Images; Mario Tama/Getty Images Paramount Skydance has agreed to pause its mega-merger with Warner Bros. Discovery until five days after the antitrust cases are ruled on, or until June 1, 2027, whichever comes sooner, the company said on Friday.
Paramount is facing an antitrust lawsuit from 12 US states and a legal challenge from the Writers Guild of America.
This decision means Paramount will almost certainly head to court to defend its deal to acquire WBD, unless settlements are reached. That will likely mean a delay of months.
David Ellison's media company had been hoping to close its WBD deal by mid-July. Paramount has agreed to pay WBD shareholders a so-called "ticking fee" of about $7 million each day the deal doesn't close, starting after September 30. Paramount lawyer Jeffrey Kessler told the judge in a hearing that the company "would suffer very severe harm" if it had to pay the ticking fee, which is $650 million per quarter.
Some of the 12 Paramount employees Business Insider talked to earlier this week said they were worried about what a delay in the WBD deal would mean for the company's financial health.
"I'm definitely worried about impending layoffs post-merger," one Paramount worker said. "But I'm worried about the company as a whole if it doesn't go through."
A Paramount spokesperson said in a statement that this agreement "is the fastest and clearest way to prove that this transaction is good for competition, good for consumers, and good for creators, a conclusion dozens of competition authorities around the world have already reached."
Paramount's WBD deal has received approval from the US Department of Justice, the European Union, and other global regulators.
Forrester research director Mike Proulx said Paramount's WBD deal "just got longer, messier, and likely more expensive."
"I'm not sure how Paramount can frame this as a win when the deal just became more uncertain than it was 24 hours ago," Proulx said. "The timeline is now out of Paramount's control."
Shares of Paramount and WBD each fell on the news. Paramount's stock finished the day down 3.3% while WBD shares slid about 0.7%.
'Tired of mergers and chaos'The states suing to stop Paramount's WBD acquisition said the deal raised antitrust concerns in three markets: wide-release film distribution, big-budget movie distribution, and cable network licensing.
With WBD, Paramount would control two top film studios in Paramount Pictures and Warner Bros. Studios; TV networks like HBO, CBS, and CNN; and streaming services Paramount+, Pluto TV, and HBO Max.
Paramount's spokesperson said these concerns about concentration "bear no relationship to the realities of today's marketplace and cannot withstand scrutiny," adding that the company would "look forward to proving our case at trial."
California Attorney General Rob Bonta said on social media that the agreement to pause the merger was "great news for audiences, movie theaters, and the many people who write, build, and create the art, news, and entertainment so many of us enjoy."
Staffers at Ellison's company have been on edge about the WBD deal and antitrust challenges.
Some told Business Insider they believed the deal would improve their job security as Paramount grew stronger, while others thought the merger would lead to overlap that could put their roles at risk.
A pro-deal Paramount streaming employee said they "see Paramount in the same light as Spirit Airlines. Regulators didn't let JetBlue and Spirit Airlines merge. Now Spirit is bankrupt, and JetBlue is struggling."
A Paramount streaming staffer who didn't like the deal said they were "tired of mergers and chaos."
Read next
James Faris You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Paramount Skydance prodloužila lhůtu pro nabídky na výměnu a odkup dluhopisů až do 7. srpna 2026. K 23. červenci bylo nabídnuto 66,17 % dluhopisů v rámci odkupu a 76,38 % dluhopisů v rámci výměny.
, /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today announced the extension of the Expiration Dates in connection with the previously announced (i) offers to purchase (the "Tender Offers" and each, a "Tender Offer") for cash, upon the terms and subject to the conditions set forth in the related offer to purchase (the "Offer to Purchase"), any and all of the identified notes in each series of the Existing Tender Offer Notes (defined by reference to the table set forth below) issued by Discovery Global Holdings, Inc. (formerly WarnerMedia Holdings, Inc.) (the "DGH Issuer") and Discovery Communications, LLC (the "DCL Issuer" and together with the DGH Issuer, each a "WBD Issuer" and collectively the "WBD Issuers"), as applicable, and (ii) offers to exchange (the "Exchange Offers" and each, an "Exchange Offer" and, together with the Tender Offers, the "Offers" and each, an "Offer"), upon the terms and subject to the conditions set forth in the related exchange offer memorandum (the "Offering Memorandum"), any and all of the identified notes in each series of the Existing Exchange Offer Notes (defined by reference to the table set forth below) (together with the Existing Tender Offer Notes, the "Offer Notes") issued by the applicable WBD Issuer for notes to be newly issued by Paramount.
The Expiration Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) have been extended to 5:00 p.m., New York City time, on August 7, 2026, unless further extended. The Settlement Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) will occur promptly after the Expiration Date and are currently anticipated to occur in the third quarter of 2026. Paramount anticipates extending the Expiration Date for such Tender Offers and Exchange Offers until such time that would result in the Settlement Dates occurring on or promptly following the closing date of the proposed acquisition (the "Acquisition") by Paramount of Warner Bros. Discovery, Inc. ("WBD"). Tenders of the Offer Notes in the Offers may be withdrawn at any time prior to the Expiration Date. The aforementioned extensions further extend the Expiration Dates previously extended by Paramount on June 12, 2026, June 26, 2026, July 13, 2026, and July 17, 2026.
As of 5:00 p.m., New York City time, on July 23, 2026, approximately 66.17% and 76.38% of the aggregate principal amount of the Existing Tender Offer Notes and Existing Exchange Offer Notes, respectively, have been validly tendered in the applicable Offers. As Paramount previously announced that it anticipates extending the Offers to align with the closing date of the Acquisition, Paramount does not view these figures to be representative of the final results of the applicable Offers.
Information about each series of Offer Notes eligible to participate in the Offers is summarized below.
Type of Offer
Offer Notes to be Tendered
or Exchanged, as
Applicable
Issuer of Offer Notes
CUSIP No. / Common Code
/ ISIN Eligible to
Participate in the Offers (1)
Aggregate Principal
Amount of Offer Notes
Eligible to Participate in the
Offers (2)
Tender Offer
3.950% Senior Notes due 2028
DCL Issuer
25470D CP2
US25470DCP24
$1,234,458,000
Exchange Offer
4.125% Senior Notes due 2029
DCL Issuer
25470D CQ0
US25470DCQ07
$655,825,000
Exchange Offer
3.625% Senior Notes due 2030
DCL Issuer
25470D CR8
US25470DCR89
$914,183,000
Exchange Offer
5.000% Senior Notes due 2037
DCL Issuer
25470D CS6
US25470DCS62
$453,281,000
Exchange Offer
6.350% Senior Notes due 2040
DCL Issuer
25470D CT4
US25470DCT46
$438,102,000
Exchange Offer
4.950% Senior Notes due 2042
DCL Issuer
25470D CU1
US25470DCU19
$130,366,000
Exchange Offer
4.875% Senior Notes due 2043
DCL Issuer
25470D V91 CV9US25470DC
$141,584,000
Exchange Offer
5.200% Senior Notes due 2047
DCL Issuer
25470D W74 CW7US25470DC
$3,161,000
Exchange Offer
5.300% Senior Notes due 2049
DCL Issuer
25470D X57 CX5US25470DC
$247,860,000
Tender Offer
3.755% Senior Notes due 2027
DGH Issuer
254948 AH5
US254948AH58
254948 AN2
US254948AN27
U25483 AA3
USU25483AA38
$1,189,336,000
Exchange Offer
4.054% Senior Notes due 2029
DGH Issuer
254948 AJ1
US254948AJ15
254948 AP7
US254948AP74
U25483 AB1
USU25483AB11
$1,353,828,000
Exchange Offer
4.279% Senior Notes due 2032
DGH Issuer
254948 AK8
US254948AK87
254948 AQ5
US254948AQ57
$2,691,764,000
Exchange Offer
5.050% Senior Notes due 2042
DGH Issuer
254948 AL6
US254948AL60
254948 AR3
US254948AR31
U25483 AD7
USU25483AD76
$4,104,687,000
Exchange Offer
5.141% Senior Notes due 2052
DGH Issuer
254948 AM4
US254948AM44
254948 AS1
US254948AS14
$949,883,000
Exchange Offer
4.302% Senior Notes due 2030
DGH Issuer
XS3393993285
339399328
€234,382,000
Exchange Offer
4.693% Senior Notes due 2033
DGH Issuer
XS3393994507
339399450
€316,641,000
1
No representation is made as to the correctness or accuracy of the identifiers listed in this press release or printed on the Offer Notes. Such identifiers are provided solely for the convenience of the holders.
2
Represents the aggregate principal amount of Offer Notes outstanding that are eligible to participate in the Offers.
The Exchange Offers are being made pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Securities Act"), and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder, and are also not being registered under any state or foreign securities laws. Any securities offered pursuant to the Exchange Offers may not be offered or sold in the United States or to any U.S. persons (as defined below) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Exchange Offers will only be made, and the securities offered pursuant to the Exchange Offers are only being offered and issued, to holders of applicable Existing Exchange Offer Notes who are (a) reasonably believed to be "qualified institutional buyers" as defined in Rule 144A under the Securities Act or (b) not "U.S. persons," as defined in Rule 902 of Regulation S under the Securities Act (such holders, "Eligible Holders"), and only Eligible Holders who have completed and returned the eligibility certification are authorized to receive or review the Offering Memorandum or to participate in the Exchange Offers. The eligibility certification is available electronically at: https://gbsc-usa.com/eligibility/paramount.
General
Each Offer is a separate offer, and each may be individually consummated, amended, extended, terminated, or withdrawn, subject to certain conditions and applicable law, at any time in Paramount's sole discretion, and without also consummating, amending, extending, terminating, or withdrawing any other Offer with respect to any other series of Offer Notes. Paramount may terminate an Offer if any of the conditions of such Offer described in the Offer to Purchase or Offering Memorandum, as applicable, are not satisfied or waived by the applicable Expiration Date, subject to applicable law. In addition, Paramount may waive the conditions to an Offer without extending such Offer in accordance with applicable law.
The Offers are being made solely by Paramount and are not being made by WBD or the WBD Issuers. None of Paramount, WBD, the WBD Issuers, the Dealer Managers, the Exchange Agent (as defined below), the Information Agent (as defined below), the trustees under each of the indentures governing the Offer Notes, the trustee or collateral agent under the indenture that will govern the notes to be issued in the Exchange Offers, or any affiliate of any of them makes any recommendation as to whether any holder of Offer Notes should tender or refrain from tendering all or any portion of the principal amount of such holder's Offer Notes for cash or notes to be issued in the Exchange Offers. No one has been authorized by any of them to make such a recommendation. Holders must make their own decision whether to tender Offer Notes in any Offer and, if so, the amount of Offer Notes to tender.
Only Eligible Holders may receive a copy of the Offering Memorandum and participate in the Exchange Offers. Paramount has engaged Global Bondholder Services Corporation to act as the exchange agent (in such capacity, the "Exchange Agent") and information agent (in such capacity, the "Information Agent") for the Offers. Questions concerning the Offers, or requests for additional copies of the Offer to Purchase or Offering Memorandum or other related documents, may be directed to Corporate Actions by telephone at (855) 654-2014 (U.S. toll-free) or (212) 430-3774 (banks and brokers) or by email at [email protected]. Holders should also consult their broker, dealer, commercial bank, trust company or other institution for assistance concerning the Offers. The Exchange Offer documents and the Tender Offer documents can be accessed at the following link: https://gbsc-usa.com/paramount.
Paramount has engaged BofA Securities and Citigroup as dealer managers (in such capacity, the "Dealer Managers") for the Offers. Holders with questions regarding the Offers should contact BofA Securities, Inc. at +1 (888) 292-0070 (toll-free) or +1 (980) 388-3646 (collect) or [email protected] or Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 or [email protected]. Latham & Watkins LLP is serving as legal counsel to Paramount and Cahill Gordon & Reindel LLP is serving as legal counsel to the Dealer Managers.
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security, and does not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.
About Paramount, a Skydance Corporation
Paramount, a Skydance Corporation is a next-generation global media and entertainment company, comprised of three business segments: Studios, Direct-to-Consumer, and TV Media. PSKY's portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS, CBS News, CBS Sports, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV, and Skydance Animation, Film, Television, Interactive/Games, and Paramount Sports Entertainment.
This communication contains "forward-looking statements" regarding the Acquisition and the other transactions referred to herein. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Paramount. Risks and uncertainties include, but are not limited to: the risk that the closing conditions for the Acquisition will not be satisfied, including the risk that clearances under applicable antitrust or regulatory laws will not be obtained or will be obtained subject to conditions that are not anticipated; the possibility that the transactions described herein will not be completed in the expected timeframe or at all; the occurrence of any event, change or other circumstances that could give rise to the termination of the Acquisition; potential adverse effects to the businesses of Paramount or WBD during the pendency of the Acquisition, such as employee departures or distraction of management from business operations; negative effects of the announcement or the consummation of the Acquisition on the market price of WBD or Paramount stock; the risk of stockholder litigation relating to the Acquisition, including resulting expense or delay; the potential that the expected benefits and opportunities of the Acquisition, if completed, may not be realized or may take longer to realize than expected; risks related to the streaming business of the post-Acquisition combined business (the "Combined Company"); the adverse impact on the Combined Company's advertising revenues as a result of changes in consumer behavior, advertising market conditions, and deficiencies in audience measurement; risks related to operating in highly competitive and dynamic industries; the unpredictable nature of consumer behavior, as well as evolving technologies and distribution models; risks related to the Combined Company's decision to invest in new businesses, products, services, and technologies, and the evolution of the Combined Company's business strategy; the potential for loss of carriage or other reduction in, or the impact of negotiations for, the distribution of the Combined Company's content; damage to the Combined Company's reputation or brands; losses due to asset impairment charges for goodwill, content and long-lived assets, including finite-lived intangible assets; liabilities related to discontinued operations and former businesses; increasing scrutiny of, and evolving expectations for, sustainability initiatives; evolving business continuity, cybersecurity, privacy and data protection and similar risks; challenges in protecting and maintaining the Combined Company's intellectual property rights; domestic and global political, economic and regulatory factors affecting the Combined Company's business generally or the Acquisition; the inability to hire or retain key employees or secure creative talent; disruptions to the Combined Company's operations as a result of labor disputes; risks and costs associated with the integration of, and Paramount's ability to integrate, the businesses of Paramount Global, Skydance Media, LLC, and WBD successfully and to achieve anticipated synergies, including in the amounts or on the timelines anticipated to realize such synergies; litigation related to the Acquisition and other matters or transactions; risks associated with the Combined Company's holding company structure, including its dependence on distributions from its subsidiaries to meet tax obligations and other cash requirements; risks related to our indebtedness, including our substantial outstanding debt obligations, our ability to incur substantially more debt and our ability to meet the financial and other covenants contained in the agreements governing the indebtedness of Paramount, WBD, or the Combined Company. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Paramount and WBD can be found in Paramount's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," Paramount's most recently filed Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 4, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," and Paramount's subsequent filings with the SEC, and in WBD's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 27, 2026, including in the section captioned "Item 1A. Risk Factors," WBD's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 6, 2026, and WBD's subsequent filings with the SEC. Neither Paramount nor WBD undertakes to update any forward-looking statement as a result of new information or future events or developments, except as required by law.
Ovintiv Inc. (OVV) Q2 2026 Earnings Call July 24, 2026 11:00 AM EDT
Company Participants
Jason Verhaest
Brendan McCracken - President, CEO & Director
Corey Code - Executive VP & CFO
Gregory Givens - Executive VP & COO
Conference Call Participants
Neil Mehta - Goldman Sachs Group, Inc., Research Division
Greg Pardy - RBC Capital Markets, Research Division
Neal Dingmann - William Blair & Company L.L.C., Research Division
Arun Jayaram - JPMorgan Chase & Co, Research Division
Douglas George Blyth Leggate - Wolfe Research, LLC
Gabe Daoud - Truist Securities, Inc., Research Division
Scott Gruber - Citigroup Inc., Research Division
Christopher Baker - Evercore ISI Institutional Equities, Research Division
John Annis - Texas Capital Securities, Research Division
Kevin MacCurdy - Pickering Energy Partners Insights
Phillip Jungwirth - BMO Capital Markets Equity Research
Presentation
Operator
Good day, ladies and gentlemen, and thank you for standing by. Welcome to Ovintiv's 2026 Second Quarter Results Conference Call. As a reminder, today's call is being recorded. [Operator Instructions] Please be advised that this conference call may not be recorded or rebroadcast without the expressed consent of Ovintiv.
I would now like to turn the conference call over to Jason Verhaest from Investor Relations. Please go ahead, Mr. Verhaest.
Jason Verhaest
Thanks, Joanna, and welcome, everyone, to our second quarter '26 conference call. This call is being webcast, and the slides are available on our website at ovintiv.com. Please take note of the advisory regarding forward-looking statements at the beginning of our slides and in our disclosure documents filed on EDGAR and SEDAR+. Following prepared remarks, we will be available to take your questions.
I will now turn the call over to our President and CEO, Brendan McCracken.
Brendan McCracken
President, CEO & Director
Thanks, Jason. Good morning, everybody, and thank you for joining us. Our second quarter results demonstrate the strength of our durable return strategy and the business
Dva inženýři Volkswagen čelí obvinění z obchodování zasvěcených osob kvůli údajné sázce na Rivian před oznámením joint venture. Podle žaloby vydělali více než 300 000 USD.
The U.S. Department of Justice has charged two Volkswagen engineers with securities fraud for an alleged insider-trading scheme connected to the German automaker’s joint venture with Rivian.
The indictment, unsealed Friday by the U.S. District Attorney for the Southern District of New York, alleges that Michael Stamp and Marcus Plank made more than $300,000 by using confidential insider information. Stamp and Plank allegedly bought Rivian stock and options after learning that the EV maker and Volkswagen planned to form a joint venture — internally codenamed “Project Climb” — but before the companies made any public announcements.
Rivian and Volkswagen announced plans for the joint venture on June 25, 2024, which would focus on developing electric vehicle architecture and software. Volkswagen initially committed to invest $5 billion in Rivian, with the capital to be released as the companies achieve certain milestones. The joint venture has since grown to $5.8 billion, and Volkswagen is now Rivian’s largest shareholder.
Rivian’s stock price rose 23% following the initial announcement in June. Stamp and Plank then allegedly sold their Rivian positions, with Stamp realized about $250,000 in profits, Plank realizing about $50,000, and Plank’s close family member realizing about $12,000, as detailed in the indictment.
“Michael Stamp and Marcus Plank’s alleged exploitation of their employer’s confidential information allowed them to make more than $300,000 in illegal profits,” U.S. Attorney Jay Clayton said in a statement Friday. “When people misuse confidential information for their own financial gain, they undermine the principles that allow our markets to function fairly and efficiently. Insider trading is a crime that New Yorkers want pursued with vigor. Its effects ripple through the financial system, harming ordinary investors and eroding public confidence. Today’s charges underscore the commitment of this Office and our law enforcement partners to protecting the integrity of our markets and holding accountable those who choose to violate the law.”
Investigators allege the two engineers understood their actions were illegal. Eight days prior to the joint venture was announced, Stamp searched “statute of limitations insider trading,” and Plank’s close family member searched, in German, “how is insider trading prosecuted?,” according to the indictment.
The pair, who both live in San Jose, were arrested Friday and will appear in the U.S. District Court for the Northern District of California. The case has been assigned to U.S. District Judge Katherine Polk Failla. Stamp and Plank face up to 25 years in prison if convicted of federal securities fraud.
TechCrunch has reached out to Rivian and Volkswagen for comment and will update the article if either company responds.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Kirsten Korosec is a reporter and editor who has covered the future of transportation from EVs and autonomous vehicles to urban air mobility and in-car tech for more than a decade. She is currently the transportation editor at TechCrunch and co-host of TechCrunch’s Equity podcast. She is also co-founder and co-host of the podcast, “The Autonocast.” She previously wrote for Fortune, The Verge, Bloomberg, MIT Technology Review and CBS Interactive.
You can contact or verify outreach from Kirsten by emailing [email protected] or via encrypted message at kkorosec.07 on Signal.
NRG v roce 2026 plánuje vrátit akcionářům 1,4 miliardy USD, z toho 1 miliardu USD prostřednictvím zpětných odkupů a téměř 407 milionů USD na dividendách. Zároveň chce investovat asi 310 milionů USD do růstu.
Key Takeaways NRG plans $1 billion in 2026 buybacks and nearly $407 million in dividends. NRG will invest about $310 million in growth, including 1.5 GW of Texas Energy Fund projects. Rising AI data-center, manufacturing and electrification demand support NRG's long-term growth. NRG Energy, Inc. (NRG - Free Report) , through systematic capital allocation, utilizes its cash to grow and create shareholder value through reinvestment, debt repayment, acquisitions, dividends and share buybacks. The company is making strategic capital investments across its business segments, generating attractive returns and enhancing shareholder value.
In 2026, NRG Energy plans to return $1.4 billion to shareholders through $1 billion of share repurchases and nearly $407 million in dividends. Rising electricity demand from AI data centers, manufacturing and electrification is strengthening NRG Energy’s long-term growth prospects. Growing investments in AI infrastructure are driving demand for reliable power, creating additional opportunities for the company’s generation business.
The company plans to invest approximately $310 million in growth initiatives during 2026. NRG is advancing 1.5 gigawatts of Texas Energy Fund projects, integrating the LS Power acquisition, expanding opportunities in data centers and providing flexible demand solutions. These investments are expected to drive long-term earnings growth while supporting disciplined capital allocation.
Capital Allocation Strengthens Shareholder ReturnsCapital allocation strengthens shareholder returns by balancing growth investments with disciplined cash deployment. Utilities invest in grid modernization while returning excess cash through dividends and share repurchases. This balanced capital allocation supports earnings growth, boosts per-share value and enhances long-term shareholder returns.
Vistra (VST - Free Report) returned about $600 million through dividends and share repurchases by May 1, 2026. It has repurchased $6.3 billion of shares since 2021, reducing share count by 30%, with $1.5 billion in buyback authorization remaining through 2027.
Constellation Energy (CEG - Free Report) repurchased 1.2 million shares for approximately $335 million in the first quarter of 2026 stock pullback, demonstrating confidence in its long-term value and
commitment to enhancing shareholder returns.
The Zacks Rundown on NRGNRG’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates a year-over-year increase of 10.16% and 26.55%, respectively.
Image Source: Zacks Investment Research
NRG’s Returns on Equity (ROE)NRG Energy's trailing-12-month ROE is 70.67%, ahead of the industry average of 11.21%.
Image Source: Zacks Investment Research
NRG’s Stock Price PerformanceIn the past month, NRG Energy’s shares have risen 0.2% compared with the industry’s 1% growth.
Coherent těží z AI infrastruktury: segment Datacenter & Communications tvořil 75 % tržeb za třetí fiskální čtvrtletí 2026 a meziročně vzrostl o 41 %.
Akcie COHR jsou letos výše o 70 %.
Key Takeaways COHR's AI infrastructure focus drives 41% YoY growth in its data center segment.Multi-year cloud commitments transition COHR away from traditional hardware cycles.COHR outperforms peers like LITE and FN with strong demand and growth visibility. Coherent’s (COHR - Free Report) transformation is increasingly being driven by the rapid expansion of AI infrastructure, positioning the company as a key supplier to one of the fastest-growing segments of the technology industry. As hyperscale cloud providers and enterprises continue investing heavily in AI computing, demand for high-speed optical connectivity has accelerated, strengthening Coherent’s role within next-generation data center networks.
The company's Datacenter & Communications segment has emerged as its primary growth engine, contributing 75% of third-quarter fiscal 2026 revenues while delivering impressive 41% year-over-year growth. This reflects the growing importance of optical transceivers, networking components, and photonic technologies that enable AI clusters to transfer massive volumes of data with low latency and high efficiency.
More importantly, this shift is changing the nature of Coherent’s business. Hardware manufacturers have traditionally faced cyclical demand, fluctuating orders and short product lifecycles that often resulted in uneven financial performance. Coherent is increasingly benefiting from a different dynamic. Its products are becoming integral to long-term AI infrastructure projects, where investments are supported by multi-year cloud expansion plans rather than short-term replacement cycles.
This transition provides greater visibility into future demand and improves the quality of the company’s revenue base. As AI deployments continue scaling, customers are making longer-term commitments to critical networking infrastructure, reducing the uncertainty typically associated with hardware businesses.
With AI infrastructure spending expected to remain a strategic priority for cloud providers and enterprise customers, Coherent appears well positioned to benefit from sustained demand. Its growing exposure to this structural trend could support more durable revenue growth while strengthening its long-term investment appeal.
Coherent Continues to Outperform Key Peers
Compared with optical networking peers Lumentum (LITE - Free Report) and Fabrinet (FN - Free Report) , Coherent continues to benefit from stronger exposure to AI infrastructure investments and increasing demand for high-speed optical connectivity. While LITE and FN are well-positioned to capitalize on data center upgrades, Coherent has strengthened its competitive standing through manufacturing expansion, long-term customer commitments, and improved backlog visibility.
The company is also demonstrating an ability to translate robust demand into profitable growth while maintaining confidence in future expansion. As AI infrastructure spending continues to accelerate, Lumentum, Fabrinet and Coherent are all expected to benefit. However, Coherent currently combines superior growth visibility, expanding production capacity and a more attractive post-correction valuation, making it stand out among its optical networking peers.
COHR’s Price Performance, Valuation and Estimates
The stock has surged a massive 70% year to date against the industry’s 7% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, COHR trades at a forward price-to-earnings ratio of 35.93X, well above the industry’s 21.2X. It carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for the company’s fiscal 2026 earnings has declined over the past 60 days.
COHR currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Badger Meter tento týden klesly o 18 % po smíšených výsledcích za 2. čtvrtletí. Tržby spadly o 7 % a EPS o 13 %, navíc výhled počítá jen s téměř stagnujícím růstem tržeb v roce 2026.
Shares of leading smart water metering solutions provider Bader Meter (BMI +2.80%) are down 18% this week as of 1 p.m. ET on Friday after the company reported mixed second-quarter earnings on Wednesday. Sales and earnings per share dropped 7% and 13%, respectively, which ever-so-slightly top Wall Street's low expectations. However, despite sneaking past analysts' hopes, the stock still sold off, as the market had hoped for a bigger potential rebound in the second half of the year but only got "flattish" sales growth guidance for 2026.
Badger Meter stock is down 34% over the last year, but I view this as more of a buying opportunity than a major concern for a couple of reasons.
Today's Change
(
2.80
%) $
3.45
Current Price
$
126.65
First, Badger Meter was priced for perfection throughout most of the last five years, trading at an average of 42 times free cash flow (FCF). Its sales growth temporarily stalled and turned negative, leaving the company trading at a much more reasonable 24 times FCF.
Image source: Getty Images.
Second -- and while a shift from sales doubling between 2020 and 2025 to two straight quarters of declining revenue might seem jarring -- it shouldn't prove to be a long-term issue for Badger Meter. Instead, it seems to be a culmination of unfortunate timing issues (linked to government budgetary issues or delays) that have resulted in nine major utility projects being slated for deployment in the second half of 2026. Once these deployments take hold, Badger Meter's sequential sales growth should extend into the coming quarters, and investors should monitor it to ensure it happens.
Zooming out and removing this year's cyclicality and timing issues, Badger Meter's overall investment thesis remains in place, in my opinion. Water and metering infrastructure throughout the U.S. (and in many parts of the world where the company is expanding) need to not only be replaced but also often updated with Badger's advanced metering infrastructure.
Growing its dividend for 21 consecutive years while delivering 13% annualized total returns over the same period, Badger Meter remains an elite, steady-Eddie compounder, finally trading at a very reasonable price again.
Josh Kohn-Lindquist has positions in Badger Meter. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Meta zavádí v některých trzích nové funkce, díky nimž Meta AI zvládne vybrané úkoly samostatně. Novinka běží na modelu Muse Spark 1.1 a časem se rozšíří i na WhatsApp.
A 3D-printed Meta logo and word "AI" are seen in this illustration taken July 20, 2026. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
July 24 (Reuters) - Meta (META.O), opens new tab is rolling out new features for its Meta AI service in select markets, allowing the chatbot to complete certain tasks autonomously, the company said on Friday.
The updated Meta AI, powered by the company's new Muse Spark 1.1 model, is designed to understand user context and execute tasks without constant prompting.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Here are some details:
Meta said new upgrades to its AI will help deliver daily briefings by summarizing calendar events and can be set up for recurring tasks such as weekly meal plans or trend updates.
The company is initially releasing these capabilities in select markets via the Meta AI app and meta.ai, with plans to expand to more regions and platforms including WhatsApp.
The Facebook parent said users retain control over how they interact with the AI and incognito chats remain available for private conversations.
"This is our next step toward personal superintelligence: an AI that knows your context, is there for you whenever you need it," Meta said in a blog post.
Separately, the company on Friday launched a new app called "Seller" to offer dedicated selling tools to merchants using the company's Facebook Marketplace platform.
Meta is scheduled to report second-quarter results after market close on July 29.
Reporting by Jaspreet Singh in Bengaluru; Editing by Pooja Desai
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Moody’s varuje, že bezprecedentní výdaje na AI zhoršují úvěrovou kvalitu Amazonu, Meta, Alphabetu a dalších hyperscalerů. Kapitálové výdaje mají v roce 2026 dosáhnout 785 miliard USD a v příštím roce zhruba 1 bilionu USD.
The race to build artificial intelligence infrastructure at a trillion-dollar annual clip is eroding the free cash flow and increasing balance-sheet risk at so-called hyperscalers, warned Moody's Ratings.
In a research note released this week, Moody's said that the spending surge is forcing even the world's most cash-rich corporations like Alphabet and Microsoft to lean heavily on debt, stock sales and off-balance-sheet moves to fund their AI ambitions.
"Previously, these companies relied on asset-light structures centered on software, intellectual property, and scalable cloud services that required modest capital investment," Moody's said in the Wednesday note. "The transition from asset-light to asset-heavy models requires unprecedented levels of investment and capital raising."
The moves "threaten credit quality" for the six companies tracked by Moody's, which include Microsoft, Amazon, Alphabet, Meta, Oracle and CoreWeave, according to the report.
The ratings firm projects that capital expenditures — or capex, which are investment for physical assets like data centers — will hit $785 billion in 2026 before reaching about $1 trillion next year.
The shift breaks a decades-long Silicon Valley formula that created the world's most valuable companies. Software costs little to replicate, yielding fat profit margins and fortress balance sheets. Generative AI, by contrast, demands a vast physical footprint: warehouses crammed with expensive and energy-hungry servers and chips.
To finance the expansion, tech giants are increasingly turning to Wall Street, resulting in booming profits for the financial industry.
Direct debt across the six hyperscalers has reached approximately $460 billion, according to Moody's. Tech companies are also tapping public markets for cash, including Google-parent Alphabet, which last month announced an $85 billion equity sale.
Leasing data centersThe ratings firm noted that because AI hardware and infrastructure require massive upfront investment while revenue materializes over a longer time horizon, free cash flow across the sector is coming under pressure.
To keep direct debt off their balance sheets, hyperscalers are leaning on off-balance-sheet financing, mostly through long-term data center leases, the report explained.
Moody's said that lease commitments across the group have ballooned to $1.2 trillion. More than $820 billion of that total is from leases that haven't started yet, meaning the data centers are still being built.
While these obligations don't show up as traditional debt, Moody's says it considers them as debt-equivalent liabilities that will bind companies to significant rent payments down the line.
Despite the warning, Moody's noted that Microsoft, Alphabet, Amazon and Meta retain among the strongest corporate balance sheets in the world, making it unlikely that their investment grade ratings are under imminent threat.
The immediate pressure is concentrated on lower-rated entities like Oracle and specialized AI cloud provider CoreWeave. Oracle carries a rating of Baa2 with a negative outlook, placing it just two notches above junk status.
Meanwhile, CoreWeave operates within the high-yield market with a Ba3 rating, relying on complex private debt structures to finance its GPU hardware fleets.
Circular ecosystem Moody's also pointed to structural circularity within the AI boom. Some of the multibillion-dollar backlogs reported by hyperscalers stem from strategic deals with pre-IPO artificial intelligence labs including OpenAI and Anthropic, Moody's noted.
The firms have invested billions into AI labs that, in turn, spend heavily on cloud computing from those same companies, creating what Moody's described as a circular AI ecosystem.
The overlapping relationships heighten risks because many of the industry's biggest companies are increasingly dependent on the same AI customers and the same assumptions about future demand, Moody's said.
Even so, the tech giants have significant strengths that help offset those risks.
Demand for AI computing remains robust, cloud businesses continue to grow and hyperscalers have signed hundreds of billions of dollars in long-term customer contracts that should provide predictable revenue. Those deals support the industry's largely-strong credit profiles, even amid the spending boom.
Still, investors should recognize that the tech industry's financial profile is undergoing a structural change unlike anything seen in the cloud era, according to Moody's.
"Investors will increasingly focus on these companies' ability to realize an adequate return on investment," the ratings firm said.
Wedbush zvýšila cílovou cenu AMD na 600 USD z 450 USD po konferenci Advancing AI 2026. Důvodem je silnější výhled pro AI v datových centrech díky novým partnerstvím a lepším dodávkám.
Advanced Micro Devices Inc (NASDAQ:AMD, XETRA:AMD) saw its price target raised to $600 from $450 by Wedbush following the chipmaker’s Advancing AI 2026 event, with the analysts writing that new partnerships and improving supply chain conditions increased confidence in the company’s data center AI growth trajectory.
AMD hosted its Advancing AI 2026 event on Wednesday and Thursday, featuring a keynote presentation from CEO Lisa Su and management followed by an investor roundtable. Wedbush noted that management avoided discussing near-term financial performance ahead of AMD’s second-quarter 2026 earnings report, leaving the event focused primarily on the company’s broader AI strategy.
The analysts wrote that AMD is increasingly positioning itself as an “end-to-end compute franchise” spanning GPUs, CPUs, networking, software, client computing and physical AI, while highlighting a broad group of enterprise and frontier AI partners.
“Net, we came away incrementally more constructive on AMD's competitive trajectory,” Wedbush wrote, adding that conversations with server vendors and supply chain participants around the event pointed to continued acceleration in AI infrastructure investment and opportunities across the broader ecosystem.
Wedbush wrote that newly announced agreements with Microsoft and Anthropic provided greater confidence that AMD’s data center AI silicon and systems revenue will “substantially accelerate” in the second half of 2026 and through 2027.
The analysts also highlighted improving supply conditions, writing that AMD appears to be making progress in addressing constraints and meeting elevated customer demand for data center compute. Based on the event and industry checks, Wedbush increased its assumptions for AMD’s data center CPU and GPU revenue growth in 2026 and 2027, lifting its revenue and earnings expectations.
Wedbush also pointed to AMD’s partnership with Cerebras, writing that the collaboration combines Cerebras’ Wafer Scale Engine technology with AMD systems to target ultra-low-latency AI inference workloads. Initial deployments are expected later this year through Cerebras Cloud.
The analysts wrote that the relationship is likely to be revenue accretive compared with prior expectations for Cerebras and represents further validation of the company’s approach to delivering high-speed AI inference capabilities.
Wedbush also highlighted VAST Data as a potential beneficiary of AI infrastructure spending, writing that the privately held company appears to have emerged as a significant supplier of data management solutions for neocloud and AI model-building customers.
While the analysts noted that VAST’s software licenses can represent a meaningful cost for customers, they wrote that users highlighted benefits including improved storage efficiency, ease of use and faster returns on cloud infrastructure investments.
On Super Micro Computer, Wedbush wrote that industry conversations supported the view that the company’s recent margin expansion could be partly sustainable, potentially driven by a shift toward higher-value deployments and tight supply conditions. However, the analysts noted they would have greater confidence in the margin outlook with additional feedback on changes within Super Micro’s business.
Wedbush said continued AI infrastructure investment should support further growth across the sector, citing conversations with neocloud providers, data center builders, server vendors and component suppliers that pointed to ongoing acceleration in data center expansion.
The analysts also highlighted memory demand tied to AMD’s AI products, noting that newer Instinct offerings are expected to require significantly more high-bandwidth memory. Wedbush wrote that tight NAND and DRAM availability could continue until additional supply comes online in 2028, with price increases potentially starting at 20% in the third quarter and exceeding 30% in some cases.
Shares of AMD are up more than 150% so far this year, trading hands at $538 on Friday afternoon.
Nokia rozšiřuje byznys mimo telekomunikace do AI sítí, cloudové konektivity a podnikové infrastruktury. Ve čtvrtletí se jí tržby z AI a cloudu meziročně více než zdvojnásobily díky poptávce po síťové infrastruktuře pro datová centra AI.
Key Takeaways Nokia is expanding beyond telecom through AI networking, cloud connectivity and enterprise infrastructure.NOK's AI and Cloud revenues more than doubled, supported by demand for AI data center networking.Nokia is investing in 5G, Open RAN and optical infrastructure while expanding enterprise opportunities. Nokia Corporation (NOK - Free Report) is evolving beyond its traditional telecom equipment business by expanding into AI networking, cloud connectivity and enterprise infrastructure. As investment in artificial intelligence accelerates, the company is benefiting from rising demand for high-speed networking solutions while continuing to serve wireless operators worldwide. Investors are increasingly evaluating whether this broader business mix can drive sustainable long-term growth despite the cyclical nature of telecom spending.
How Nokia Builds Growth Across Its BusinessNokia operates through four primary business segments: Mobile Infrastructure, Network Infrastructure, Portfolio Businesses and Technology Licensing. Mobile Infrastructure remains the largest contributor, providing radio access products and software for wireless carriers. Meanwhile, Network Infrastructure has become an increasingly important growth engine through its Optical Networks, IP Networks and Fixed Networks businesses, serving telecom operators, cloud providers and enterprise customers.
The Portfolio Businesses segment expands Nokia's software and enterprise offerings, while Technology Licensing generates recurring revenues from one of the industry's largest wireless patent portfolios. This diversified structure helps reduce reliance on any single business while supporting more balanced long-term growth.
Why NOK Is Expanding Beyond Telecom CyclesAI is becoming a major growth driver for Nokia. During the latest quarter, AI and Cloud revenues more than doubled year over year, supported by strong demand for networking infrastructure powering AI data centers. Management also reported robust AI order activity, reinforcing confidence in future revenue opportunities.
Growth in Optical Networks and IP Networks further highlights Nokia's expanding exposure beyond traditional carrier spending. These businesses support hyperscale cloud providers and enterprises building AI infrastructure, creating additional revenue streams that complement the company's mobile networking operations. Similar opportunities are also attracting networking leaders such as Cisco Systems (CSCO - Free Report) and optical networking specialist Ciena Corporation (CIEN - Free Report) as AI infrastructure investment continues to accelerate.
How Nokia Strengthens Its Technology EdgeNokia continues investing in technologies that support long-term competitiveness. Its 5G portfolio, ReefShark chipsets and Open RAN initiatives are designed to improve network performance while lowering customer operating costs. The company also benefits from an extensive patent portfolio that supports recurring licensing revenue in addition to equipment sales.
Management is also expanding manufacturing capabilities and optimizing the business portfolio to focus more heavily on AI networking, optical infrastructure and enterprise solutions. These initiatives strengthen Nokia's position in faster-growing markets while supporting long-term profitability.
What Risks Could Slow NOK's ProgressDespite improving growth prospects, Nokia continues to face several challenges. Telecom capital spending remains cyclical, and customer investment timing can create quarterly revenue volatility. The company also operates in highly competitive networking markets while executing restructuring initiatives designed to improve long-term efficiency.
Additional risks include geopolitical uncertainty, supply constraints and changing global trade conditions, all of which could affect customer demand and project execution. Successfully balancing these challenges while expanding AI-related businesses will remain important for future growth.
How NOK's Ratings Fit the Growth StoryNokia currently carries a Zacks Rank #3 (Hold) with a Value Score of B, Growth Score of C, Momentum Score of A and VGM Score of B. These ratings reflect a company benefiting from improving AI infrastructure demand and attractive valuation characteristics while still facing execution risks and telecom market cyclicality. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Overall, Nokia is building a more diversified networking business by expanding beyond traditional telecom infrastructure into AI, cloud and enterprise networking. While industry headwinds remain, continued strength in Network Infrastructure, licensing and AI-related demand provides meaningful long-term opportunities. The current Hold rating reflects a balanced outlook as investors monitor execution and the pace of AI-driven growth.
NVIDIA v 1. čtvrtletí fiskálního roku 2027 zvýšila tržby na 81,615 miliardy USD a tržby z datových center vyskočily meziročně o 92 %. Firma zároveň čeká ve 2. čtvrtletí tržby 91,0 miliardy USD.
I keep hitting the buy button on NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) because every quarter AI capex grows larger, and NVIDIA collects at each layer. Hyperscalers order racks, sovereigns order factories, enterprises order runtime. That is the conviction.
The Thesis in One Sentence NVIDIA monetizes today’s hardware cycle at rack scale while building the software and networking tollbooth for the next one. Jensen Huang framed it plainly on the last call: “The buildout of AI factories, the largest infrastructure expansion in human history, is accelerating at extraordinary speed.” The custom thesis is the same one management executes: turnkey Blackwell racks proprietary NVLink interconnects capture today’s capex, then NIM microservices, CUDA, and NVLink Fusion fabric licensing turn one-time hardware sales into structural, compounding cash flow.
Three Reasons the Money Keeps Going Here First, operating leverage is delivering. Fiscal 2026 revenue landed at $215.9 billion, up from $130.5 billion the year prior, with net income of $120.1 billion and operating margin of 60.4%. SG&A fell from 9.0% of revenue in FY2023 to 2.1% in FY2026. Companies do not scale like this without pricing power.
Second, the current quarter confirms the story. Q1 FY2027 revenue hit $81.615 billion, beating consensus by 3.16% on non-GAAP EPS of $1.87, a fourth straight beat. Data Center revenue reached $75.246 billion, up 92% year over year, with networking growing 199%. Gross margin came in at 75.0%. Q2 guide points to $91.0 billion in revenue.
Third, valuation remains reasonable. Forward P/E sits at 23 with a PEG of 0.559. Return on equity is 114.3%. Management authorized an $80.0 billion repurchase and lifted the dividend from $0.01 to $0.25 per share. Retirement accounts get paid to wait.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Why Not the Obvious Alternatives The two names I get asked about are Broadcom (NASDAQ:AVGO) and Marvell Technology (NASDAQ:MRVL). Broadcom’s CEO targets over $100 billion in AI revenue by 2027. That is a 2027 aspiration. NVIDIA already printed $75.2 billion in Data Center revenue in a single quarter. Marvell trades at 47x forward earnings, roughly double NVIDIA’s 23 forward multiple, for slower growth. I would rather own the platform every custom silicon design still has to interconnect with.
The Risk I Refuse to Wave Off China is the real risk. Huang called it out directly: “Losing access to the China AI accelerator market, which we believe will grow to nearly $50 billion, would have a material adverse impact on our business.” The company took a $4.5 billion H20 inventory charge and shipped zero H20 units to China in Q1 FY2027. That is real money. It has not changed my thesis because NVIDIA grew Data Center 92% year over year with China effectively zeroed out, and total supply commitments now stand at $119.0 billion. The rest of the world is absorbing the capacity.
Why the Buy Button Stays Active Analyst consensus is 58 buys to 1 sell with a $302.31 target. This works as long as AI factories keep growing, software attach keeps rising, and NVLink remains the fabric everyone standardizes on. Every quarter so far, that is exactly what has happened. Until that pipeline changes, my money keeps going in.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Nvidia, Microsoft a další technologičtí giganti vyzvali zákonodárce, aby neomezovali open-source AI modely. Tvrdí, že by to brzdilo konkurenci i inovace.
Item 1 of 3 NVIDIA logo and word "Artificial Intelligence" are seen in this illustration taken July 20, 2026. REUTERS/Dado Ruvic/Illustration
[1/3]NVIDIA logo and word "Artificial Intelligence" are seen in this illustration taken July 20, 2026. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
SummaryCompaniesTwo dozen companies, including Meta and IBM, sign letterThey urge lawmakers to avoid 'premature restrictions' on open-source AI modelsUS lawmakers propose AI model kill switches after a rogue OpenAI cyberattackSAN FRANCISCO, July 24 (Reuters) - Nvidia (NVDA.O), opens new tab, Microsoft (MSFT.O), opens new tab and other tech heavyweights made a public case to lawmakers on Friday in favor of open-source AI models, wading into a debate roiling the business and policy worlds over who controls the powerful technology.
In a letter posted on X and also signed by two dozen companies and groups including Meta Platforms (META.O), opens new tab and IBM , Nvidia CEO Jensen Huang said that lawmakers should avoid "premature restrictions on open models that stifle competition or drive innovation overseas."
Make sense of global markets with the Trading Day newsletter. Sign up here.
The letter adds to the growing debate about open-source models that are harder to regulate, such as Nvidia's own and those released in recent weeks by Chinese labs, and the closed-source models controlled by specific companies such as OpenAI and Anthropic.
In recent months, Silicon Valley business leaders have bristled at the cost of closed source models. The CEOs of Microsoft and defense contractor Palantir Technologies (PLTR.O), opens new tab have publicly argued that open-source models their customers can run inside their own data centers will help control AI costs.
Tech leaders have also chafed at controls that OpenAI and Anthropic build into their models. Hugging Face, the AI coding collaboration site that was hacked by a rogue OpenAI model, this week said that it had to use a Chinese open-source model to defend against the attack because closed-source models have restrictions on use for cybersecurity work.
At the same time, U.S. lawmakers alarmed by the rogue OpenAI cyberattack proposed legislation that would require a "kill switch" for AI models, and President Donald Trump's administration is weighing sanctions on Chinese open-source model makers over alleged theft of U.S. closed-source technology.
The letter from Nvidia and other companies acknowledged the concerns about technology theft but argued they should be addressed "through targeted legal and commercial frameworks rather than sweeping restrictions."
"Relying solely on closed models is not inherently safe: they can be breached, misused, or fail in ways that outsiders cannot detect," the letter said. "Open weight models, on the other hand, allow a broad community of researchers and developers to examine their behavior, identify vulnerabilities, develop safeguards, and improve them over time."
Reporting by Stephen Nellis in San Francisco; Editing by Emelia Sithole-Matarise
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Qualcomm logo is displayed at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 5, 2025. REUTERS/Maxim Shemetov Purchase Licensing Rights, opens new tab
July 24 (Reuters) - Smartphone chipmaker Qualcomm (QCOM.O), opens new tab has told customers it would raise prices by a percentage in the double digits due to rising costs, Bloomberg News reported on Friday, citing a letter sent to clients.
The San Diego, California-based company did not immediately respond to a Reuters request for comment. Its shares were trading down more than 1%.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Here are some details:
The company sent the letter to customers on Friday, informing them that the price hike will go into effect for products shipped after September 1, the report said.
Reuters could not independently verify the report.
Qualcomm told customers that it could no longer absorb rising supplier costs and had sought alternative components from new suppliers, the report said.
The report comes as Qualcomm grapples with mounting pressure in the smartphone market, squeezed by a memory chip shortage as investment is redirected toward AI infrastructure.
Qualcomm is set to report its third-quarter results on July 29.
Reporting by Anhata Rooprai in Bengaluru; Editing by Shilpi Majumdar
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Intel rozšiřuje AI napříč PC, podniky i cloudem a současně zvyšuje výrobu na Intel 18A, zatímco pokračuje vývoj 14A. Firma těží z rostoucí poptávky po AI infrastruktuře.
Key Takeaways Intel is expanding AI across PCs, enterprise systems, edge computing and AI infrastructure.INTC ramped Intel 18A production while advancing 14A development and advanced packaging.Intel is growing AI infrastructure exposure through Xeon, networking, custom silicon and cloud partnerships. Artificial intelligence is reshaping the semiconductor industry, creating new opportunities across data centers, enterprise computing, networking and advanced manufacturing. For Intel Corporation (INTC - Free Report) , these trends are driving a broader transformation that extends well beyond its traditional PC business.
The company's ability to capitalize on AI infrastructure demand while executing its manufacturing roadmap will likely play a central role in determining its long-term growth trajectory.
Intel Pushes AI Beyond Traditional PCsIntel is expanding its AI strategy across commercial and consumer markets by integrating artificial intelligence capabilities into PCs, enterprise systems and edge computing platforms. The company has repositioned its client business around both traditional computing and physical AI applications, reflecting growing demand for local AI processing across a wider range of devices.
Beyond AI PCs, Intel continues investing in enterprise AI infrastructure, robotics and edge deployments. Its expanding portfolio enables customers to process AI workloads closer to where data is generated, supporting applications that require lower latency, enhanced security and improved real-time performance.
INTC Advances the Next Foundry CycleIntel's manufacturing roadmap continues to make measurable progress. The company has ramped Intel 18A into volume production for multiple products while reporting improving yields, higher factory output and better cycle times across its manufacturing network.
Looking ahead, Intel remains on track with Intel 14A development, including continued progress on process technology and customer engagement. At the same time, advanced packaging technologies such as EMIB-T and growing external foundry relationships highlight Intel's broader effort to transform its manufacturing business into a long-term competitive advantage serving both internal products and third-party customers.
Intel Benefits From AI Infrastructure DemandAI infrastructure demand is expanding well beyond graphics processors, creating opportunities across CPUs, networking, custom silicon and advanced packaging. Intel is benefiting from stronger adoption of Xeon processors as enterprises and hyperscale customers build increasingly sophisticated AI environments.
The company is also strengthening its position through networking products, purpose-built silicon, advanced packaging technologies and collaborations with enterprise customers and cloud providers. These initiatives support Intel's participation across multiple layers of AI infrastructure rather than concentrating on a single product category.
Advanced Micro Devices, Inc. (AMD - Free Report) continues expanding its presence in server processors and AI computing, while NVIDIA Corporation (NVDA - Free Report) remains the market leader in AI accelerators. Intel's diversified product portfolio and manufacturing capabilities provide an alternative competitive approach as enterprise AI deployments continue to broaden.
INTC Navigates Industry HeadwindsDespite favorable industry trends, Intel continues operating in a highly competitive and capital-intensive environment. Manufacturing execution remains essential as the company scales advanced process technologies while balancing production costs and customer commitments.
Broader industry challenges also remain. Supply constraints affecting leading-edge components, fluctuations in memory markets, aggressive competition across CPUs, GPUs, networking and application-specific integrated circuits, along with elevated capital spending requirements, could influence how effectively Intel converts emerging AI opportunities into sustained financial growth.
How Intel's Rating Reflects the Trend StoryIntel's strategic transformation is increasingly tied to long-term technology trends rather than the traditional PC replacement cycle. Continued execution across AI products, manufacturing and foundry services will remain critical as these opportunities evolve.
The stock currently carries a Zacks Rank #1 (Strong Buy), reflecting improving earnings estimate momentum. You can see the complete list of today’s Zacks #1 Rank stocks here. However, its VGM Score of D indicates that its overall combination of value, growth and momentum characteristics remains relatively modest. The Value Score of F and Growth Score of C contrast with a stronger Momentum Score of B, suggesting the market currently places greater weight on Intel's improving operational momentum while investors continue to monitor whether long-term execution translates into stronger value and growth characteristics.
Key Takeaways Intel is expanding beyond PCs with AI, enterprise, edge computing, foundry and autonomous driving businesses.Intel's foundry utilization, yields and factory output improved, with narrower operating losses.INTC's growing AI adoption through Xeon, AI PCs, networking, packaging and cloud and enterprise partnerships. Intel Corporation (INTC - Free Report) is reshaping its business around artificial intelligence, enterprise infrastructure and advanced manufacturing as it reduces its reliance on the traditional PC market. The company's long-term investment case increasingly depends on its ability to execute across these strategic priorities while strengthening its manufacturing leadership.
Recent results suggest Intel is making progress. Stronger demand for AI infrastructure, improving foundry execution and expanding customer adoption across multiple product categories are helping reinforce confidence in its turnaround strategy.
Intel Expands Beyond the PC MarketIntel has steadily diversified beyond its legacy PC business by focusing on data-centric markets that include AI infrastructure, enterprise computing, edge computing and autonomous driving. Its operating structure now reflects this transition, with dedicated businesses serving client computing, data center and AI, manufacturing, networking and Mobileye's autonomous driving platform.
A major strategic shift has been the adoption of Intel's internal foundry operating model. By separating product development from manufacturing operations, the company aims to improve transparency, accountability and cost discipline while increasing manufacturing efficiency. The structure also supports Intel's broader ambition to become a leading foundry serving both internal products and third-party customers.
INTC Builds Momentum Across AI PlatformsArtificial intelligence has become a key growth driver across Intel's portfolio. Demand for Xeon processors continues to strengthen as enterprises and hyperscale customers expand AI infrastructure beyond graphics processors into CPUs, networking and purpose-built silicon. The company has also broadened its AI offerings with AI PCs, Arc Pro graphics solutions, networking products and advanced packaging technologies.
Intel is expanding customer adoption through partnerships spanning cloud providers, enterprise customers and industry-specific AI deployments. Continued investment in purpose-built silicon, physical AI and advanced packaging should further strengthen its position across data center, edge and enterprise workloads.
Competition remains intense from Advanced Micro Devices, Inc. (AMD - Free Report) , which continues expanding its presence in data center processors and AI accelerators. NVIDIA Corporation (NVDA - Free Report) also remains a dominant force in AI infrastructure through its GPU ecosystem, underscoring the importance of Intel's differentiated CPU, networking and manufacturing strategy.
Intel Foundry Becomes a Strategic Growth EngineIntel Foundry has become one of the company's most important long-term growth initiatives. The business reported improving factory utilization, better manufacturing yields and significantly higher factory output, while operating losses narrowed as production efficiency improved.
Management also highlighted meaningful reductions in Panther Lake wafer costs, continued progress on Intel 18A manufacturing and development milestones for Intel 14A. External customer engagement continues to expand alongside growing demand for advanced packaging services, reinforcing Intel's effort to establish foundry services as a meaningful long-term revenue driver.
INTC Faces Execution and Competitive RisksDespite encouraging progress, Intel still faces significant execution challenges. Manufacturing leadership depends on successfully ramping advanced process technologies while maintaining cost discipline and meeting customer commitments.
The competitive landscape also remains challenging across CPUs, GPUs, application-specific integrated circuits, networking and custom silicon. Elevated capital expenditures, ongoing industry supply constraints and geopolitical uncertainty could continue creating operational and financial headwinds as Intel scales its manufacturing investments.
How Intel's Rating Fits the Current ThesisIntel's long-term outlook increasingly depends on consistent execution across AI products, manufacturing and foundry services. Continued progress in these areas could strengthen its competitive positioning as enterprise AI adoption expands.
The stock currently sports a Zacks Rank #1 (Strong Buy), reflecting improving earnings momentum. You can see the complete list of today’s Zacks #1 Rank stocks here. However, its VGM Score of D suggests its overall combination of value, growth and momentum characteristics remains relatively weak. That weaker composite score largely reflects a Value Score of F and Growth Score of C, although the Momentum Score of B indicates comparatively stronger price and earnings momentum. Together, these measures suggest that while earnings expectations have improved, investors may still want to balance Intel's improving momentum against its more modest value and growth characteristics before making investment decisions.
American Express uvedla, že Gen Z je jejím růstovým motorem: jejich útraty vzrostly meziročně o 40 % a tvořily 65 % nových globálních spotřebitelských účtů. Společnost zároveň zvýšila celoroční výhled růstu tržeb z 9 % až 10 % na 10 %.
Gen Z is becoming American Express’ growth engine, with young customers driving faster spending growth and most new consumer account openings.
Dining is evolving into a loyalty platform, as Amex uses Resy, Tock and the proposed TheFork acquisition to connect reservations, benefits and payments.
Amex sees its closed-loop data as an AI advantage, giving it more context to verify customer intent, manage fraud and support agentic commerce.
American Express’ second-quarter earnings tell a spending story that stretches from restaurant tables to airport gates to corporate expense accounts, with artificial intelligence sitting somewhere in the middle.
Card spending rose 9% on an FX-adjusted basis in the second quarter, according to a Friday (July 24) earnings presentation. Travel and entertainment spending increased 10%, goods and services rose 9%, and consumer spending in the United States climbed 11%, its fastest growth since early 2018 excluding pandemic-distorted periods. Commercial spending, which has been considerably slower, accelerated to 5%.
The spending was broad-based across categories. Retail spending rose 13%, restaurant spending increased 10%, airlines were up 10%, and American Express travel bookings jumped 22%. Millennials and Generation Z remained the fastest-growing U.S. consumer cohorts and now account for the largest share of U.S. consumer spending on Amex cards.
CEO Stephen Squeri said during an analyst Q&A on a Friday conference call that the spending gains reflect more than new customer acquisition.
“Engagement has been really accelerated, and that’s driving a lot of the spending,” Squeri said, adding that “restaurant spend was up 10%, but when you look at Resy restaurant spend, it’s double that.”
The engagement is increasingly coming from young customers. Gen Z spending rose 40% year over year, compared with 14% for millennials, 10% for Generation X and 5% for baby boomers and older customers. Millennials and Gen Z together accounted for 38% of U.S. consumer-billed business. Meanwhile, 65% of new global consumer accounts came from those two generations.
The income story is more nuanced. Chief Financial Officer Christophe Le Caillec said during the call that young customers generally enter the Amex franchise with low income initially, but “we’re going to grow with them, and they’re going to grow with us.”
Restaurants Become More Than a Card Category Dining is also becoming a deliberate part of Amex’s strategy.
Restaurant spending is the company’s largest travel and entertainment category, and Amex is building infrastructure around that spending rather than simply collecting interchange when the check arrives. Its proposed acquisition of TheFork would add 50,000 restaurants across 11 European countries to a dining portfolio that already includes Resy and Tock.
Squeri said Amex is effectively creating smaller closed loops inside its larger payments network by connecting cardholders directly with restaurants. Amex cardholders also generate higher average tickets than non-cardholders. The platforms can additionally serve as acquisition channels by offering cardholders special access and benefits while remaining open to nonmembers.
The closed-loop argument becomes more consequential as commerce starts shifting toward AI agents.
Squeri said agentic commerce creates new questions around fraud, customer intent and AI hallucinations. Amex’s pitch is that it has information from both sides of a transaction.
“We know what the customer wanted to do, and we’ll also know what the merchant delivered,” he said during the call.
However, he cautioned against assuming agentic commerce is already mature.
“We’re sort of in the preseason,” Squeri said. “We’re not even … in the early innings.”
Amex is spending accordingly. Squeri said technology investment now includes agentic commerce initiatives that were not contemplated when the company established its original 2026 spending plans.
The business side is getting similar attention. Commercial billed business rose 5%, with U.S. small- to medium-sized businesses and large/global corporations growing at the same rate. Travel and entertainment spending among commercial customers rose 8%, twice the 4% increase in goods and services spending. Amex has also begun piloting a new expense management platform with middle-market customers, an area where management acknowledged competitive pressure from FinTech providers.
CFO Le Caillec said the stronger spending translated into 10% revenue growth, a rate that was below Wall Street’s expectations, and shares dipped 5% in early trading Friday. The company raised its full-year revenue growth forecast from a range of 9% to 10% to 10%.
American Express Company (AXP) Q2 2026 Earnings Call July 24, 2026 8:30 AM EDT
Company Participants
Kartik Ramachandran - Senior VP & Head of Investor Relations
Stephen Squeri - Chairman & CEO
Christophe Le Caillec - Chief Financial Officer
Conference Call Participants
Sanjay Sakhrani - Keefe, Bruyette, & Woods, Inc., Research Division
Ryan Nash - Goldman Sachs Group, Inc., Research Division
Donald Fandetti - Wells Fargo Securities, LLC, Research Division
Craig Maurer - Financial Technology Partners LP
Richard Shane - JPMorgan Chase & Co, Research Division
Mark DeVries - Deutsche Bank AG, Research Division
Terry Ma - Barclays Bank PLC, Research Division
Robert Wildhack - Autonomous Research US LP
Darrin Peller - Wolfe Research, LLC
Bill Carcache - Piper Sandler & Co., Research Division
Mihir Bhatia - BofA Securities, Research Division
Presentation
Operator
Welcome to the American Express Q2 2026 Earnings Call. [Operator Instructions] As a reminder, today's call is being recorded.
I will now turn the call over to Kartik Ramachandran, Head of Investor Relations. Please go ahead.
Kartik Ramachandran
Senior VP & Head of Investor Relations
Thank you, Dana, and thank you all for joining today's call. Today's discussion contains forward-looking statements about the company's future business and financial performance. These are based on management's current expectations and are subject to risks and uncertainties. Factors that could cause actual results to differ materially from these statements are included in today's presentation slides and in our reports on file with the SEC.
Today's discussion also contains non-GAAP financial measures. Comparable GAAP financial measures are included in this quarter's earnings materials as well as the prior period earnings materials discussed today. All of these are posted on our website at ir.americanexpress.com. We will begin today with Stephen Squeri, Chairman and CEO; followed by Christophe Le Caillec, Chief Financial Officer. After their remarks, we'll move to Q&A.
NextEra Energy, Inc. (NEE) Q2 2026 Earnings Call July 24, 2026 9:00 AM EDT
Company Participants
Michael Dowling
John Ketchum - President, CEO & Chairman
Michael Dunne - CFO & Executive VP of Finance
Scott Bores - President & CEO
Brian Bolster - CEO & President
Conference Call Participants
Steven Fleishman - Wolfe Research, LLC
Julien Dumoulin-Smith - Jefferies LLC, Research Division
Nicholas Campanella - Barclays Bank PLC, Research Division
Jeremy Tonet - JPMorgan Chase & Co, Research Division
Carly Davenport - Goldman Sachs Group, Inc., Research Division
Presentation
Operator
Good day, and welcome to the NextEra Energy, Inc. Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Michael Dowling, Director of Investor Relations. Please go ahead.
Michael Dowling
Good morning, everyone, and thank you for joining our second quarter 2026 financial results conference call for NextEra Energy. With me this morning are John Ketchum, Chairman, President and Chief Executive Officer of NextEra Energy; Mike Dunne, Executive Vice President and Chief Financial Officer of NextEra Energy; Armando Pimentel, Vice Chairman of NextEra Energy; Scott Bores, President and Chief Executive Officer of Florida Power & Light Company; Brian Bolster, President and Chief Executive Officer of NextEra Energy Resources; and Mark Hickson, Executive Vice President of NextEra Energy.
John will start with opening remarks, and then Mike will provide an overview of our results. Our executive team will then be available to answer your questions.
We will be making forward-looking statements during this call based on current expectations and assumptions, which are subject to risks and uncertainties. Actual results could differ materially from our forward-looking statements if any of our key assumptions are incorrect or because of other factors discussed in today's earnings news release, in the comments made during this conference call, in the
Eli Lilly ve 1. čtvrtletí zvýšila tržby o 55,5 % a FDA vyčistila Foundayo, první perorální GLP-1 užívaný kdykoli během dne. Firma zároveň navýšila celoroční výhled o 2 miliardy USD.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Eli Lilly (NYSE:LLY | LLY Price Prediction) has accelerated despite its $1 trillion scale. Revenue grew 55.5% in Q1 2026, management raised full-year guidance by $2 billion, and the FDA cleared Foundayo, the first any-time-of-day oral GLP-1.
Our 24/7 Wall St. price target for Eli Lilly is $1,365.51, implying roughly 15% upside from the current $1,186.85. We rate LLY a buy with high (90%) confidence.
24/7 Wall St. Price Target Summary Metric Value Current Price $1,186.85 24/7 Wall St. Price Target $1,365.51 Upside ~15.1% Recommendation BUY Confidence 90% Foundayo Reset the Growth Story LLY is up 8.59% year-to-date and 50.84% over the trailing year, recovering from an April low of $903.99.
Q1 2026 delivered $19.80 billion in revenue, beating the $17.80 billion consensus, with non-GAAP EPS of $8.55 versus the $6.79 estimate. Mounjaro revenue jumped 125% to $8.66 billion and Zepbound climbed 80% to $4.16 billion.
Recent headlines mixed bullish coverage of the $6.3 billion Centessa acquisition and a $6.5 billion Houston manufacturing plant against a fresh Novo Nordisk lawsuit alleging deceptive GLP-1 comparison ads.
The Case for $1,429 and Higher Bulls argue Foundayo unlocks an oral obesity market that injectables never fully addressed. CEO Dave Ricks noted the drug can reach “over 1 billion people around the world with obesity and related conditions” with regulatory reviews underway in over 40 countries. Early launch data showed 80% of prescriptions were new-to-class.
Retatrutide, the next-gen triple agonist, delivered up to 37 pounds of weight loss in Phase 3. Morningstar flagged LLY as positioned for “industry-leading growth”. Our bull-case scenario carries the stock to $1,429.03, roughly 12.5% above current levels.
What Could Go Wrong Pricing pressures loom. Q1 realized prices fell 13%, offsetting a 65% volume gain, and Mounjaro’s inclusion on China’s National Reimbursed Drug List will pressure international prices. Novo Nordisk’s false-advertising lawsuit and emerging generic semaglutide competition add legal and competitive headwinds.
_________________________________
What's Your Number...?Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
Q1 carried $584 million in IPR&D charges plus $279 million in litigation and restructuring. Most charges reflect deliberate M&A spend (Centessa, Orna, Kelonia, Ajax) that expands the pipeline. Our bear scenario prices LLY at $1,123.10, an 11.6% drawdown.
How Eli Lilly Compares to Merck and Novo Nordisk Merck (NYSE:MRK) is the value counterpoint. Merck guided FY2026 revenue of $65.8 billion to $67 billion and non-GAAP EPS of $5.04 to $5.16, with Q1 growth of just 4.87%. That is a fraction of Lilly’s 55.5% pace, explaining why Lilly commands a forward P/E of 33x while Merck trades at mid-teens multiples. Growth still wins.
Novo Nordisk (NYSE:NVO) is the direct GLP-1 rival. Novo’s Q1 underlying adjusted sales fell 4% at constant currency, and management guided full-year growth to -4% to -12% CER after slashing Wegovy list prices by roughly 50% effective January 2027. Against that peer set, our LLY target looks reasonable.
Eli Lilly Price Prediction 2026-2030 Our 24/7 Wall St. price target of $1,365.51 reflects a buy rating with 90% confidence. Foundayo converts a large injectable-averse population into addressable demand.
The setup looks constructive if the Foundayo launch tracks to plan into Q3, and more cautious if realized prices deteriorate past mid-teens headwinds. Growth of this quality at this scale is rare.
Year 24/7 Wall St. Price Target 2026 $1,365.51 2027 $1,470 2028 $1,565 2029 $1,640 2030 $1,711.70 These projections assume Lilly executes on Foundayo, retatrutide, and pipeline acquisitions. Significant upside or downside could result from GLP-1 pricing regulation, Novo Nordisk competition, or acceleration of oral obesity adoption globally.
If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:
Answer a Few Simple Questions.
Get Matched with Vetted Advisors
Choose Your Fit
Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
Strategy vytvořila dolarovou rezervu ve výši 3,225 miliardy USD, která pokrývá zhruba 1,8 roku ročních úroků a dividend. Firma ale dál zůstává silně závislá na Bitcoinu a nese vysoký dluh i závazky z preferenčních akcií.
Key Takeaways Strategy's dollar reserve covers roughly 1.8 years of annual interest and dividend costs.Bitcoin sales, share repurchases and reserve funding tools may reduce forced financing in weak markets.Strategy still faces high debt, preferred-stock obligations, dilution risk and Bitcoin dependence. Strategy (MSTR - Free Report) has shifted from nonstop Bitcoin accumulation toward protecting its cash position. As of July 24, 2026, it held 843,775 BTC and a $3.225 billion reserve after selling more than 2.7 million MSTR shares for about $263.5 million.
The reserve is restricted mainly to preferred-stock dividends and debt interest. Strategy reports annual interest and dividend costs of about $1.76 billion, so the current reserve offers roughly 1.8 years of coverage.
The latest news shows why that buffer matters. Strategy sold 3,588 BTC in early July for about $216 million, its first major sale after years of steady buying, and disclosed an $8.32 billion second-quarter digital-asset loss.
The company has also approved up to $1 billion each for preferred-share and MSTR repurchases, plus Bitcoin sales of up to $1.25 billion to refill reserves. These tools may reduce forced financing during weak markets and give management flexibility when Bitcoin prices fall sharply.
However, risk remains high, because the reserve improves liquidity without reducing dependence on Bitcoin. Strategy carries about $6.75 billion of debt and $15.46 billion of preferred stock, while MSTR’s valuation premium has fallen near 1.0 times net asset value. Raising cash may, therefore, require more dilution or further Bitcoin sales.
How Are MARA Holdings and Strive Managing Bitcoin Risk?MARA Holdings (MARA - Free Report) has paired treasury defense with expansion. MARA Holdings sold 15,133 Bitcoin and repurchased about $1 billion of convertible notes, then agreed in July to acquire a Texas site with 2,000 megawatts of planned power. MARA Holdings gains flexibility, but development commitments could later rebuild financial pressure.
Strive (ASST - Free Report) held 19,921 Bitcoin and $157.4 million in cash on July 17 after buying 21 more coins. Strive also held $43.1 million of Strategy preferred shares. Strive has liquidity, yet share issuance and Bitcoin volatility still create fixed-payment and dilution risks for investors.
MSTR’s Price Performance, Valuation and EstimatesShares of MSTR have declined 44.1% over the past three months compared with the industry’s fall of 4.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, Strategy remains highly expensive, trading at a forward 12-month price-to-sales ratio of 65.55, which is far above the sector's average. Its Value Score of F reinforces concerns that the stock is significantly overvalued.
Image Source: Zacks Investment Research
Over the past 30 days, earnings estimates for both 2026 and 2027 have been revised downward, signaling a bearish outlook from analysts.
AON čeká ve 2. čtvrtletí růst tržeb o 2,6 % na 4,26 miliardy USD a EPS 3,77 USD. Tahounem mají být Commercial Risk Solutions a Health Solutions, ale výsledky mohou brzdit vyšší náklady.
Key Takeaways AON is expected to post Q2 revenue growth, led by Commercial Risk Solutions and Health Solutions.AON's four straight earnings beats and favorable retention rates point to potential upside this quarter.Higher compensation, IT and other costs, plus weaker Wealth Solutions demand, may weigh on results. Leading global insurer Aon plc (AON - Free Report) is set to report second-quarter 2026 results on July 29, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.77 per share on revenues of $4.26 billion.
The second-quarter earnings estimate has witnessed two upward revisions and five downward movements over the past 60 days. The bottom-line projection indicates a year-over-year increase of 8%. The Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 2.6%.
Image Source: Zacks Investment Research
AON beat the consensus estimate for earnings in each of the last four quarters, with the average surprise being 3.1%.
Q2 Earnings Whispers for AONOur proven model predicts a likely earnings beat for the company this time around as well. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s precisely the case here.
AON has an Earnings ESP of +0.24% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping AON’s Q2 Results?The Zacks Consensus Estimate for the Commercial Risk Solutions line’s revenues indicates 5.3% growth from $2.18 billion a year ago, whereas our model predicts a 5% increase. We expect the unit to witness 5% organic revenue growth in the quarter under discussion.
The consensus mark for the Health Solutions line’s second-quarter revenues suggests nearly 6% growth from the year-ago level, while our model estimate indicates an 8% increase. The segment is likely to have been supported by new business growth, strong retention rates and positive market impact.
The Zacks Consensus Estimate for Reinsurance Solutions' revenues indicates growth of 4.4% from $688 million recorded a year ago, while our model estimate suggests a 7% increase. Favorable retention rates, new business generation and facultative placement growthare expected to have benefited the unit.
The factors mentioned above are expected to have contributed to the company's year-over-year growth, positioning it for an earnings beat. However, the positives are likely to have been partially offset by high expenses due to significant investments in priority areas for long-term growth, coupled with an uptick in certain discretionary and other costs.
Our model predicts total operating expenses for the second quarter at above $3.3 billion, attributed to increased costs related to higher compensation and benefits and information technology. Specifically, the estimate for other general expenses is set at more than $400 million, while compensation and benefits costs are pegged at nearly $2.4 billion.
Moreover, the consensus estimate for second-quarter revenues in the Wealth Solutions segment suggests a 15.2% decrease from the previous year’s $519 million, whereas our model indicates a 15% decline. The unit is likely to have been affected by weaker advisory demand in the United States.
How Did AON’s Peers Perform?Several insurance companies, including Marsh & McLennan Companies, Inc. (MRSH - Free Report) , AMERISAFE, Inc. (AMSF - Free Report) and RenaissanceRe Holdings Ltd. (RNR - Free Report) , have already reported their financial results for the June quarter of 2026. Here’s how they performed:
Marsh reported second-quarter 2026 adjusted earnings per share of $2.96, which surpassed the Zacks Consensus Estimate by 2.8%. The bottom line advanced 8.8% year over year.Its strong quarterly results benefited from solid growth in the Risk and Insurance Services and Consulting units. However, the upside was partially offset by Marsh’s elevated operating expenses, primarily due to increased compensation and benefits.
AMERISAFE reported second-quarter adjusted earnings per share of 44 cents, missing the Zacks Consensus Estimate by 17%. The bottom line also declined 17% year over year. The quarterly result was affected by higher expenses and weaker underwriting margins, with additional pressure from lower investment income. AMSF’s strong premium growth partly offset these headwinds.
RenaissanceRe reported second-quarter 2026 operating income of $12.92 per share, which surpassed the Zacks Consensus Estimate by 12.9%. The bottom line also improved 5.1% year over year. The quarterly earnings benefited from lower expenses, higher net investment income and an improved total combined ratio. However, the upside was partly offset by lower net premiums earned, weaker underwriting results in RNR’s Casualty & Specialty segment and lower fee income.
For the quarter ended June 2026, Halliburton (HAL - Free Report) reported revenue of $5.71 billion, up 3.7% over the same period last year. EPS came in at $0.55, compared to $0.55 in the year-ago quarter.
The reported revenue represents a surprise of +4.19% over the Zacks Consensus Estimate of $5.48 billion. With the consensus EPS estimate being $0.54, the EPS surprise was +1.85%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Halliburton performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Latin America: $1.12 billion compared to the $1.11 billion average estimate based on three analysts. The reported number represents a change of +14.9% year over year.Revenue- Europe/Africa/CIS: $1.02 billion versus $877.28 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +24% change.Revenue- North America: $2.28 billion versus the three-analyst average estimate of $2.25 billion. The reported number represents a year-over-year change of +0.8%.Revenue- Middle East/Asia: $1.3 billion versus the three-analyst average estimate of $1.3 billion. The reported number represents a year-over-year change of -10.7%.Revenue- Drilling and Evaluation: $2.51 billion compared to the $2.35 billion average estimate based on five analysts. The reported number represents a change of +7.4% year over year.Revenue- Completion and Production: $3.2 billion versus $3.15 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +1% change.Operating income- Completion and Production: $474 million versus the five-analyst average estimate of $480.38 million.Operating income- Drilling and Evaluation: $338 million versus $322.07 million estimated by five analysts on average.Operating income- Corporate and other: $-83 million versus the two-analyst average estimate of $-96.5 million.View all Key Company Metrics for Halliburton here>>>
Shares of Halliburton have returned -5.7% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
SLB vykázala ve 2. čtvrtletí tržby ve výši 9 miliard USD, mezičtvrtletně o 3 % vyšší, a upravený EPS činil 0,55 USD. Růst mimo Blízký východ kompenzoval 13% pokles tržeb v regionu.
AI’s Power Crunch Fuels a Pivot for These 2 Oilfield StocksSLB NYSE: SLB reported second-quarter revenue of $9 billion, up 3% sequentially, as growth in Latin America, Europe and Africa, U.S. land and Asia more than offset disruptions in the Middle East. Adjusted earnings per share were $0.55, up $0.03 from the prior quarter but down $0.19 from a year earlier, according to Chief Financial Officer Stephane Biguet.
The company said Middle East revenue declined 13% sequentially to $1.66 billion amid conflict-related operational disruptions. SLB took temporary cost actions to limit the earnings impact, and Biguet said the resulting effect on earnings per share was slightly below the low end of the company’s previously indicated $0.06 to $0.08 range.
Get SLB alerts:
MarketBeat Week in Review – 05/04 - 05/08Despite those disruptions, SLB said its pre-tax segment operating margin increased 49 basis points sequentially and adjusted EBITDA margin rose 83 basis points.
Production Systems and Digital Lead Growth Chief Executive Officer Olivier Le Peuch said growth outside the Middle East was broad-based, supported by higher offshore activity in Brazil, Guyana, Mexico, Scandinavia, Nigeria, China, Indonesia, India and Australia. U.S. land activity also improved, with higher demand for production chemicals, artificial lift and valves.
SLB’s Tough Quarter Masks a Powerful Long-Term ShiftProduction Systems was the company’s largest division in the quarter, with revenue rising 7% sequentially to $3.8 billion. The increase was driven by OneSubsea, artificial lift, valves, surface production systems and completions. Pre-tax operating margin improved 138 basis points to 15.5%, aided by better profitability in OneSubsea and artificial lift, as well as contributions from ChampionX’s Production Chemicals and Artificial Lift businesses.
Le Peuch said Production Systems adjusted EBITDA margins returned to above 20%. He added that ChampionX delivered sequential margin expansion for a third consecutive quarter despite inflation in chemicals.
Digital revenue increased 9% sequentially to $697 million, while pre-tax operating margin rose 683 basis points to 27.8%. Digital adjusted EBITDA margin reached 34.7%, up 860 basis points sequentially, driven by exploration data licenses and transfer fees in Brazil and Indonesia, along with improved profitability in digital operations, platforms and applications. SLB said digital annual recurring revenue increased 15% year over year.
Reservoir Performance revenue declined 2% sequentially to $1.6 billion, and Well Construction revenue also fell 2% to $2.7 billion, primarily because of Middle East disruptions. Well Construction margin was essentially flat as lower profitability in the Middle East was offset by improved profitability in North America and Latin America.
Middle East Recovery Remains Uneven Management said activity resumed in several Middle Eastern countries during the quarter, though operations in Iraq remained constrained by security concerns. Le Peuch said recovery will vary by country, customer and operating environment, and a return to full activity will take time.
During the question-and-answer session, Le Peuch said customer engagement had increased as operators plan to restore shut-in wells, expand capacity and deploy production-recovery solutions. He said activity had been restored and was strengthening in the United Arab Emirates, Qatar and, to some extent, Saudi Arabia, while Iraq remained more constrained.
SLB expects initial recovery work to include well intervention, production chemicals, coiled tubing and other ChampionX-related production and recovery offerings. Management also said the disruption could accelerate interest in digital tools to optimize existing wells and operations.
For the third quarter, SLB’s base case assumes a gradual Middle East recovery and calls for global sequential revenue growth of 3% to 4%, with approximately 75 basis points of adjusted EBITDA margin expansion. Core-division revenue is expected to rise in the low- to mid-single digits, while Digital revenue is projected to increase in the low single digits.
The company also outlined a downside scenario in which renewed escalation prevents remobilization efforts and leaves Middle East revenue flat sequentially. In that case, third-quarter revenue would be about $150 million below its base case and adjusted EBITDA would face an approximately $75 million headwind, primarily in Well Construction and Reservoir Performance.
Deepwater Activity and Fourth-Quarter Outlook Le Peuch said the market is beginning to show characteristics of an upcycle, citing the need to replenish inventories and strategic reserves, diversify supply, develop domestic resources and rebuild spare capacity. He said third-party reports indicate final investment decisions for long-cycle projects could increase about 30% year over year in 2026.
SLB expects stronger exploration spending and deepwater capital investment during the second half of 2026, led by Africa, with a more meaningful impact in 2027 across Latin America, the Mediterranean and Asia. Management also highlighted continued activity in Brazil, Guyana, Suriname, the North Sea and the Gulf of America.
The company reiterated its ambition for OneSubsea bookings to reach $9 billion over two years. Le Peuch said SLB is expanding its subsea portfolio, including trees, manifolds, umbilicals, processing and boosting solutions, while pursuing life-of-field service capabilities and alliances with customers and partners.
For the fourth quarter, SLB expects Middle East revenue of $2.1 billion to $2.2 billion, or roughly 95% of the level achieved in the fourth quarter of 2025. Assuming that recovery, continued deepwater momentum and typical year-end Digital product sales, the company expects fourth-quarter revenue to exceed $10 billion, representing about 5% year-over-year growth. Adjusted EBITDA margin is expected to be about 24%.
Data Center Business Expands SLB said its data center solutions revenue grew 33% sequentially and 80% year over year. The business added hyperscaler customers and expanded from equipment manufacturing into data center design, engineering and system integration.
Le Peuch said SLB uses off-site fabrication to produce modular equipment for server infrastructure and cooling systems, aiming to provide customers with shorter delivery times and scalable deployment. The company said its backlog is already sufficient to support an annualized revenue run rate exceeding $2 billion by the end of 2027.
Biguet said the data center business is not currently accretive to SLB’s overall margins, but it is accretive to revenue and earnings growth and has strong free-cash-flow characteristics because of its capital-light business model and contract terms.
SLB generated $1.4 billion in cash flow from operations and $716 million in free cash flow during the quarter. It ended the period with net debt of $8.7 billion, repurchased $648 million of stock, and maintained its full-year target to return more than $4 billion to shareholders through dividends and buybacks.
About SLB (NYSE:SLB)SLB NYSE: SLB, historically known as Schlumberger, is a leading global provider of technology, integrated project management and information solutions for the energy industry. Founded by Conrad and Marcel Schlumberger in 1926, the company develops and supplies products and services used across the exploration, drilling, completion and production phases of oil and gas development. Its offerings are intended to help operators characterize reservoirs, drill and complete wells, optimize production and manage field operations throughout the asset lifecycle.
SLB's product and service portfolio spans reservoir characterization and well testing, wireline and logging services, directional drilling and drilling tools, well construction and completion technologies, production systems, and subsea equipment.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in SLB Right Now?Before you consider SLB, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SLB wasn't on the list.
While SLB currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Ecolab čeká za 2. čtvrtletí tržby 4,4 mld. USD, tedy růst o 9,3 %, a zisk 2,08 USD na akcii, což by znamenalo zlepšení o 10,1 %. Marže mohou tlačit nahoru vyšší náklady na komodity, logistiku a energie.
Key Takeaways ECL's Q2 revenues are estimated to rise 9.3%, while earnings are projected to improve 10.1%.High-Tech, Life Sciences, Digital and Pest Elimination are expected to remain key growth drivers.Higher commodity, logistics and energy costs may pressure margins before pricing fully catches up. Ecolab (ECL - Free Report) is scheduled to release second-quarter 2026 results on July 28, before the opening bell. In the last reported quarter, the company delivered earnings in line with the estimates. ECL’s earnings beat estimates in two of the trailing four quarters, missed once and met once, delivering an average surprise of 0.23%.
Q2 Estimates
Currently, the Zacks Consensus Estimate for revenues is pegged at $4.4 billion, indicating growth of 9.3% year over year. The consensus mark for earnings is pinned at $2.08 per share, indicating an improvement of 10.1%.
Factors to Note Before ECL ReportsEcolab is expected to have delivered another quarter of organic growth, supported by continued value pricing, resilient demand across most end markets and sustained momentum in its higher-growth businesses. Global High-Tech, Digital, Life Sciences and Pest Elimination are likely to have remained the key growth drivers, benefiting from ongoing AI infrastructure investments, accelerating digital adoption, robust biopharmaceutical demand and continued customer adoption of connected pest management solutions. However, elevated commodity, logistics and energy costs, along with the temporary lag in pricing recovery, are expected to have pressured second-quarter margins and earnings growth.
Within the Global Industrial segment, Global High-Tech is expected to have maintained strong double-digit growth, supported by continued investments in semiconductor fabrication facilities, AI-driven data center expansion and rising demand for advanced water management solutions. Life Sciences is also likely to have delivered another quarter of double-digit growth, aided by robust demand for bioprocessing solutions, expanding biologics production and favorable capacity utilization. Meanwhile, Food & Beverage is expected to have outperformed its underlying markets, supported by innovation and the company's One Ecolab strategy. Paper and Heavy Water businesses, however, likely remained relatively soft despite signs of stabilization and incremental gains from new business wins.
The Global Institutional & Specialty segment is expected to have delivered steady growth, supported by continued value pricing, market share gains and demand from restaurant, lodging and quick-service restaurant customers. Specialty is likely to have remained a standout performer, benefiting from customer demand for productivity-enhancing and resource-efficient solutions that lower labor, water and energy costs. The company's One Ecolab initiative, including cross-selling efforts among its largest customers, is also expected to have supported revenue growth during the quarter.
Per management, Ecolab expects second-quarter 2026 to serve as a transition period as elevated commodity, energy and logistics costs temporarily pressure earnings before pricing actions and energy surcharges are fully realized. While the company did not provide specific revenue or earnings per share (EPS) guidance for the quarter, it expects underlying performance to remain within its long-term adjusted EPS growth target of 12-15%, with higher commodity costs expected to reduce second-quarter EPS growth by a few percentage points. Pricing is anticipated to have accelerated through the quarter, allowing Ecolab to fully offset the dollar impact of higher input costs by the end of the second quarter.
Meanwhile, favorable business mix, continued strength in higher-margin growth engines such as Global High-Tech and Life Sciences, SG&A productivity initiatives and digital efficiencies are expected to have partially cushioned inflationary pressures during the quarter. Investors will closely monitor management's commentary on pricing realization, margin recovery, demand trends across key end markets and the initial contribution and integration of the recently acquired CoolIT business, particularly as Ecolab enters the second half of 2026 with its full-year adjusted EPS growth outlook of 12-15% intact, excluding the temporary acquisition-related impact.
Earnings Beat UnlikelyOur proven model does not predict an earnings beat for ECL this earnings season. The combination of a positive Earnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +0.20%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: The company carries a Zacks Rank #4 (Sell) at present.
Stocks Worth a LookHere are some other medical product stocks worth considering, as these have the right combination of elements to post an earnings beat this reporting cycle.
Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.41% and a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
HSIC’s earnings surpassed estimates in three of the trailing four quarters and missed once, with the average surprise being 3.74%. The Zacks Consensus Estimate for HSIC’s second-quarter EPS indicates an improvement of 10.9% from the year-ago reported figure.
Alcon (ALC - Free Report) has an Earnings ESP of +3.13% and a Zacks Rank of 3 at present. The company is set to release second-quarter 2026 results on Aug. 10.
ALC’s earnings surpassed estimates in three of the trailing four quarters and missed once, with the average surprise being 3.66%. The Zacks Consensus Estimate for ALC’s second-quarter EPS implies an improvement of 1.3% from the year-ago reported figure.
Cardinal Health (CAH - Free Report) has an Earnings ESP of +1.24% and a Zacks Rank of 2 at present. The company is slated to release fourth-quarter fiscal 2026 results on Aug. 11.
CAH’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.27%. The Zacks Consensus Estimate for CAH’s fourth-quarter EPS indicates a gain of 16.4% from the year-ago reported figure.
A logo of Blackstone is pictured in Manhattan, New York City, U.S. July 29, 2025. REUTERS/Mike Segar/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesBidding for MarineMax has moved into third roundDonerail, Blackstone, Centerbridge among interested partiesInvestment firm Donerail began pushing for a sale last yearNEW YORK, July 24 (Reuters) - Investment firms Blackstone (BX.N), opens new tab and Donerail are among the final bidders to acquire MarineMax (HZO.N), opens new tab, two people familiar with the matter said on Friday, as the recreational yacht retailer explores selling itself.
The two, as well as private equity firm Centerbridge, are in the final round of bidding for the Clearwater, Florida-headquartered company, said the sources who are not permitted to discuss private deliberations.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
MarineMax, which has a market value of around $725 million, caters to a wealthy clientele through its 65 marinas and storage locations and 70 dealerships, mostly in the U.S. It has attracted significant interest at a time the marina business has become a popular investment area.
Donerail began pushing MarineMax to sell itself or replace its chief executive officer last year, intensifying pressure on the company after Levin Capital in 2024 urged management and the board to evaluate strategic alternatives.
Representatives for MarineMax, Blackstone, and Donerail declined to comment. A representative for Centerbridge did not immediately respond to a comment request.
The company has made some changes aimed at addressing concerns of disgruntled investors, including replacing board directors, but has never publicly acknowledged running a sales process including on Thursday when it reported quarterly earnings.
Reuters reported in February that Donerail submitted an all-cash offer which valued MarineMax at around $1 billion. Donerail subsequently raised its offer, while other buyout firms including Blackstone jumped into the mix as the company formally solicited buyer interest from April onwards.
Marinas and superyacht services have seen significant dealmaking in the last 18 months, with investment firms being particularly active.
Lower interest rates have supported high-end consumers' spending on luxury items like yachts even as other economic brackets are forced to tighten their belts.
Blackstone, through its infrastructure arm, bought Safe Harbor Marinas in 2025 for $5.7 billion. Fellow infrastructure investor Stonepeak acquired marina owner and operator Southern Marinas in April.
MarineMax was trading around $33.30 per share around midday on Friday, putting year-to-date gains around 37%. However, it is still trading at roughly half the value of its lifetime high hit in May 2021.
Reporting by Svea Herbst-Bayliss; Editing by David French and Sanjeev Miglani
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Jefferies za měsíc od posledních výsledků přidala asi 5,6 %, ale odhad zisků se za stejnou dobu snížil o 8,9 %. Ve 2. čtvrtletí fiskálního roku 2026 firma minula odhady EPS i tržeb, i když zaznamenala rekordní investičněbankovní výnosy.
A month has gone by since the last earnings report for Jefferies (JEF - Free Report) . Shares have added about 5.6% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Jefferies due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Jefferies Q2 Earnings Miss Estimates Despite Record IB PerformanceJefferies’ second-quarter fiscal 2026 (ended May 31) adjusted earnings per share from continuing operations of $1.03 missed the Zacks Consensus Estimate of $1.09. However, the bottom line increased significantly from the prior-year quarter.
Results were primarily aided by record IB advisory and underwriting net revenues, as well as record equities net revenues. However, a rise in expenses hurt the results to an extent.
Net earnings attributable to common shareholders (GAAP) increased significantly year over year from $88 million to $226.2 million.
Revenues Improve, Expenses RiseQuarterly net revenues were $2.21 billion, up 35% from the prior-year quarter. The top line marginally missed the Zacks Consensus Estimate of $2.22 billion.
Total non-interest expenses were $1.89 billion, up 26.1% from the year-ago quarter. The rise was due to an increase in almost all cost components, except for depreciation and amortization costs, cost of sales, and other expenses.
As of May 31, 2026, book value per common share was $51.95, up from $49.96 as of May 31, 2025. Furthermore, adjusted tangible book value per fully diluted share increased from $32.84 to $34.55.
Quarterly Segment PerformanceInvestment Banking & Capital Markets: Total Net revenues were $2.01 billion, rising 36.4% from the prior-year quarter. Investment Banking net revenues were $1.21 billion, up 57.5% year over year, driven by higher advisory and equity underwriting revenues, while debt underwriting remained solid but declined year over year. Capital Markets net revenues were $799.3 million, up 13.5%, driven by increases in both Equities and Fixed Income net revenues.
Asset Management: Net revenues were $187.7 million, up 21.4% from the year-ago quarter. Asset management fees and revenues, as well as investment return, declined year over year, but other investments, inclusive of net interest, increased.
Balance Sheet SolidAs of May 31, 2026, total assets were $79.54 billion, up from $74.38 billion as of Feb. 28, 2026, while total shareholders’ equity was $10.57 billion, down modestly from $10.61 billion.
The leverage ratio was 7.5 compared with 6.5 in the prior-year quarter, and the tangible gross leverage ratio was 9.0 compared with 7.9.
Return on adjusted tangible shareholders’ equity was 12.8%, up from 5.5% in the prior-year quarter.
Share Repurchase UpdateIn the reported quarter, Jefferies repurchased 4 million common shares for $197 million, at an average price of $49.83 per share.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -8.9% due to these changes.
VGM ScoresCurrently, Jefferies has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Jefferies has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Crocs v 1. čtvrtletí fiskálního roku 2026 čelil tlaku na marže: upravená hrubá marže klesla o 90 bazických bodů na 56,9 % a tržby značky Crocs i HEYDUDE se snížily.
Key Takeaways CROX has outperformed peers recently but faces tariff, margin and HEYDUDE-related growth challenges.Crocs is investing in international expansion, marketing and inventory discipline to support long-term growth.CROX trades below the industry P/E but above its historical median valuation despite recent share gains. Crocs, Inc. (CROX - Free Report) has seen its shares rally 28.1% in the past three months, outperforming the industry’s growth of 5.6%. The stock has also outperformed the broader sector’s 4.7% decline and the S&P 500 Index’s 4% increase over the same period.
CROX Stock’s 3-Month Performance
Image Source: Zacks Investment Research
In the past three months, CROX has trailed the performance of Vince Holding Corp. (VNCE - Free Report) while outperforming G-III Apparel Group, Ltd. (GIII - Free Report) and Columbia Sportswear Company (COLM - Free Report) . In the same period, shares of VNCE, GIII and COLM have increased 31.5%, 8.8% and 1%, respectively.
CROX’s Share Price Performance VS Peers
Image Source: Zacks Investment Research
Closing at $132.47 in the last trading session, CROX stock stands 5.7% below its 52-week high of $140.42 reached on July 17, 2026. CROX is trading above its 50-day simple moving average of $120.99 and its 200-day simple moving average of $95.95, indicating a strong technical setup.
CROX Trades Above 50 & 200-Day SMA
Image Source: Zacks Investment Research
Crocs Drives Growth Through Global ExpansionCrocs remains optimistic about its international business, expecting strong growth across its international markets for the remainder of the year and seeing a multiyear runway for expansion in key markets. Management highlighted particularly robust performance in Japan and China, noting that both continue to deliver very strong growth and reinforce the company's long-term global opportunity.
To support future growth, the company is also investing in marketing across both brands to drive demand for new product launches. At the same time, Crocs is maintaining a disciplined approach to inventory and supply chain management, using lean inventory levels to improve productivity and enhance financial flexibility.
Crocs Reports Margin Pressure and Weak Brand PerformanceDespite these long-term growth opportunities, the company is facing the impact of the Middle East conflict and expects these impacts to create several challenges for the Crocs brand. Management identified three potential areas of impact: lower revenue from its Middle East distributor business, which has already been incorporated into its annual guidance; higher raw material and transportation costs associated with elevated oil prices; and the possibility of broader macroeconomic disruptions, the extent of which remains uncertain. These factors could create additional headwinds for the business going forward.
The company faced margin pressure in the first quarter of fiscal 2026, with enterprise adjusted gross margin declining 90 basis points year over year to 56.9%. The decrease was primarily driven by a 100-basis-point impact from incremental tariffs, along with an unfavorable product mix. These headwinds were only partially offset by a favorable brand mix, resulting in an overall decline in gross margin in the first quarter.
Crocs reported weaker performance across both of its key brands in the first quarter of fiscal 2026 while continuing to execute initiatives to return both brands to growth. Sales at the Crocs brand declined 2%, while the HEYDUDE brand recorded a steeper 13% decrease. Both brands reported lower adjusted gross margins in the quarter. Adjusted gross margin for the Crocs brand declined 120 basis points to 59.5%, while the HEYDUDE brand experienced a steeper contraction of 210 basis points, bringing its adjusted gross margin to 44.5%.
Crocs issued a cautious outlook, expecting second-quarter revenues to decline slightly at prevailing currency rates, with continued weakness at the HEYDUDE brand and margin pressure from tariffs. For 2026, the company projects muted enterprise revenue growth between down 1% and up 1%, while HEYDUDE is still expected to post a 5% to 7% sales decline despite an improved outlook.
How Estimates Are Shaped Up for CROX?The Zacks Consensus Estimate for CROX’s current quarter earnings per share has been revised up by 2 cents to $4.32 in the past seven days. The consensus mark for the current year earnings per share has been revised down by a penny to $13.66, reflecting a challenging outlook for the year.
Image Source: Zacks Investment Research
CROX is currently trading at a forward 12-month P/E multiple of 9.29X, lower than the industry average of 15.70X and well below the S&P 500 multiple of 20.80X. However, the stock is trading above its 12-month median P/E of 7.11X, suggesting potential overvaluation relative to its historical valuations.
Crocs’ Valuation Picture
Image Source: Zacks Investment Research
How to Play CROX Stock?Although Crocs continues to see attractive long-term opportunities in international markets, the business is facing mounting near-term challenges that could weigh on financial performance and investor sentiment. Weakening brand momentum and pressure on profitability reduce visibility into the pace of any meaningful recovery, while ongoing macroeconomic uncertainties create additional pressures. Given these risks, existing investors may consider reducing exposure, while prospective investors may prefer to remain on the sidelines until there is clearer evidence of sustained improvement in operating performance and a more favorable business environment. At present, CROX carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
WM čeká ve 2. čtvrtletí tržby 6,7 miliardy USD, což je meziročně o 4,4 % více, a EPS 1,99 USD. Nejrychleji má růst segment obnovitelné energie, o 47 %.
Key Takeaways WM's Q2 revenues are expected to rise 4.4% y/y to $6.7 billion, with EPS up 3.7% to $1.99.Collection and disposal revenues are projected at $5.5 billion, nearly 82% of WM's quarterly sales.WM's renewable energy revenues are expected to rally 47%, helped by RNG, automation and new markets. WM (WM - Free Report) is scheduled to release second-quarter 2026 results on July 28, 2026, after market close.
WM surpassed the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, the average earnings surprise being 0.6%.
WM’s Q2 ExpectationsThe Zacks Consensus Estimate for revenues is pegged at $6.7 billion, implying a 4.4% gain from the year-ago quarter’s actual. The top line is expected to have been driven by solid momentum across the total collection and disposal segment, contributing toward the majority of the top line. The remaining segments are anticipated to have contributed meaningfully to the top line as well.
The consensus estimate for total collection and disposal segment revenue is set at $5.5 billion, suggesting a 3.9% year-over-year rise. This segment is expected to account for nearly 82% of the top line in the second quarter of 2026. Revenue gains in this segment are likely to have stemmed from a focus on customer lifetime value, continuous operational improvement and network advantages.
For the recycling processing and sales segment, the consensus estimate for revenues is $397 million. This represents a 4.2% increase from the year-ago quarter’s actual. The Zacks Consensus Estimate for the WM renewable energy segment’s revenues is $169 million, suggesting a 47% year-over-year jump. Key drivers of recycling and renewable segments’ expansion likely include investments in renewable natural gas facilities, recycling automation and new market projects.
The consensus estimate for the WM healthcare solutions revenues hints at marginal year-over-year growth to $647 million. For the corporate and other segment, the Zacks Consensus Estimate is pinned at $7 million, suggesting no change from the year-ago quarter’s reported figure.
The consensus estimate for earnings per share is pegged at $1.99, hinting at a 3.7% increase from the year-ago quarter’s actual. Bottom-line growth is anticipated to have been driven by operational efficiencies and expanding margins across segments, capturing the growth momentum. Automation and AI-fueled technological support are expected to have been the prominent growth drivers as well.
What Our Model Predicts About WMOur proven model does not conclusively predict an earnings beat for WM this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
WM currently has an Earnings ESP of -1.31% and a Zacks Rank #3.
Stocks to ConsiderHere are a few stocks from the broader Business Services sector, which, according to our model, have the right combination of elements to beat on earnings this season.
Clean Harbors (CLH - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2026 revenues is pinned at $1.6 billion, indicating 4.8% year-over-year growth. For earnings, the consensus estimate is pegged at $2.73 per share, implying a 15.7% jump from the year-ago quarter’s actual. The company beat the consensus estimate in three of the four quarters and missed once, with an average negative surprise of 0.02%.
CLH has an Earnings ESP of +3.82% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The company is scheduled to declare second-quarter 2026 results on July 29.
Veralto Corporation (VLTO - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2026 revenues is $1.4 billion, suggesting a 4.9% year-over-year rise. For earnings, the consensus estimate is kept at a dollar per share, gaining 7.5% from the year-ago quarter’s actual. The company beat the consensus estimate in the trailing four quarters, with an average surprise of 4.9%.
VLTO has an Earnings ESP of +0.77% and a Zacks Rank of 3 at present. The company is scheduled to declare second-quarter 2026 results on July 28.
Xylem má 28. července před otevřením trhu zveřejnit výsledky za 2. čtvrtletí; konsensus čeká tržby 2,33 mld. USD a zisk 1,34 USD na akcii. Tlak na marže mají vyšší náklady na materiál, práci, přepravu i investice.
Key Takeaways Xylem is expected to post higher Q2 revenues and earnings, led by infrastructure and water solution demand.XYL may benefit from smart metering demand, backlog execution and contributions from the Vacom acquisition.Xylem faces margin pressure from higher material, labor, freight and strategic investment costs. Xylem Inc. (XYL - Free Report) is scheduled to release second-quarter 2026 results on July 28, before market open.
The Zacks Consensus Estimate for XYL’s second-quarter revenues is pegged at $2.33 billion, indicating growth of 1.2% from the prior-year quarter’s number. The consensus mark for earnings is pinned at $1.34 per share, which has been stable in the past 60 days. The figure indicates an increase of 6.4% from the year-ago quarter’s figure.
The company’s earnings surpassed the Zacks Consensus Estimate thrice in the trailing four quarters and matched the mark in one, the average surprise being 5.9%.
Let’s see how things have shaped up for Xylem this earnings season.
Factors Likely to Have Shaped XYL’s Quarterly PerformanceStrength in the transport application business, aided by increased infrastructure projects in the United States, is likely to have supported the Water Infrastructure segment’s performance. The Zacks Consensus Estimate for the Water Infrastructure segment’s revenues is pegged at $664 million, indicating 2.2% growth from the year-ago figure.
An increase in demand for advanced metering infrastructure solutions, like smart and energy metering, and strong backlog execution are likely to have augmented the performance of the Measurement & Control Solutions (M&CS) segment. The Zacks Consensus Estimate for the M&CS segment’s revenues is pinned at $538 million, almost in line with the year-ago quarter’s figure.
Strength in the Applied Water segment, supported by higher demand for commercial building solutions applications, including pumps, valves and dispensing equipment, is likely to augment the segment’s results. The Zacks Consensus Estimate for the Applied Water segment’s revenues is pegged at $492 million, indicating 1.9% growth from the year-ago figure.
Recovery in Xylem’s dewatering applications business across utility and power end markets is likely to augment the Water Solutions and Services segment’s results. The Zacks Consensus Estimate for the Water Solutions and Services segment’s revenues is pegged at $636 million, indicating 1.3% growth year over year.
The company’s acquisition of Vacom Systems (in April 2025), a wastewater treatment company, enhanced its capabilities in providing sustainable water solutions. This buyout is expected to bolster the company’s top-line results in the to-be-reported quarter.
However, XYL’s bottom line is likely to have reflected the impact of high raw material costs, labor, freight and overhead costs in the second quarter. Also, increased spending on strategic investments is expected to have hurt its margins.
Earnings WhisperOur proven model does not conclusively predict an earnings beat for Xylem this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: Xylem has an Earnings ESP of -0.34%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: XYL presently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Crane Company (CR - Free Report) has an Earnings ESP of +4.73% and a Zacks Rank of 2 at present. The company is scheduled to release second-quarter 2026 results on July 28.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 11.3%.
Ingersoll Rand Inc. (IR - Free Report) has an Earnings ESP of +0.61% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on July 30.
Ingersoll Rand’s earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters while matching the mark in two, the average surprise being 2.4%.
Illinois Tool Works Inc. (ITW - Free Report) has an Earnings ESP of +0.31% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on July 28.
Illinois Tool’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.8%.
cbdMD podpořila dvoustranný Lawful Hemp Protection Act, který má zachovat přístup k legálním full-spectrum CBD a vytvořit dlouhodobý federální rámec pro konopné produkty. Firma varuje, že bez zásahu Kongresu se má definice hempu od 12. listopadu 2026 zpřísnit.
Company backs the Barr-Craig framework and the administration's call to fix the federal hemp definition before the November deadline
, /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leader in hemp-derived wellness, today announced its support for the bipartisan Lawful Hemp Protection Act, introduced July 21 by Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN). The legislation would establish a long-term federal regulatory framework for hemp-derived products while preserving consumer access to lawful products. The Company also expressed support for the Administration's call to address the federal hemp definition through pending budget legislation.
The legislation comes at a pivotal time for the U.S. hemp industry. Under Section 781 of the Fiscal Year 2026 appropriations law, the federal definition of hemp is scheduled to narrow on November 12, 2026. Without congressional action, many lawful full-spectrum CBD and hemp wellness products could be removed from the marketplace. The Lawful Hemp Protection Act would repeal that provision and replace it with a durable, science-based framework.
The bipartisan sponsorship reflects a growing consensus that responsible regulation, rather than prohibition, is the appropriate path forward for the hemp industry. The bill would establish FDA oversight for hemp-derived products, with mandatory third-party testing, transparent labeling, a 21-and-over age requirement, and domestic sourcing, while targeting the synthetic intoxicants that have drawn scrutiny to the category.
Specifically, cbdMD supports a federal framework that:
Protects access to responsibly manufactured full-spectrum CBD Requires independent testing and accurate labeling Establishes clear manufacturing and marketing standards, including limits on youth-focused marketing Prevents youth access through a 21-and-over requirement Restricts synthetic and artificially modified cannabinoids Preserves lawful interstate commerce for compliant products cbdMD also welcomed the Office of Management and Budget's recent call for Congress to update the hemp definition through the funding process, which the company believes could provide relief before the November deadline if enacted.
As one of the nation's longest-standing hemp-derived CBD companies, cbdMD believes a consistent federal regulatory framework would significantly benefit consumers and responsible businesses alike by improving consumer confidence, strengthening safety standards, and providing greater certainty for manufacturers and retailers.
"Reps. Barr and Craig have demonstrated bipartisan leadership by advancing a practical regulatory framework for hemp-derived products," said Ronan Kennedy, Chief Executive Officer of cbdMD. "Responsible companies have long supported clear federal standards that protect consumers, promote product quality, and distinguish compliant hemp products from illicit synthetic intoxicants. We encourage Congress to act before the November implementation deadline."
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is a Charlotte, North Carolina-based hemp-derived wellness company committed to safe, high-quality, science-backed products. Its family of brands includes cbdMD, cbdMD Science, Bluebird Botanicals, Paw CBD, Oasis, and ATRx Labs. For more information, visit cbdMD.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding pending legislation, regulatory developments, and their potential impact on the company are based on current expectations and are subject to risks and uncertainties, including the outcome of the legislative and regulatory processes described above and risks disclosed in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Actual results may differ materially. The company undertakes no obligation to update any forward-looking statement except as required by law.
Contacts
cbdMD, Inc.
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
[email protected]
(704) 445-3064
Generac Holdings Inc. čeká za 2. čtvrtletí tržby 1,18 miliardy USD a EPS 1,95 USD na akcii, tedy meziroční růst o 11 % a 18,2 %. Tahounem má být segment C&I díky poptávce po datových centrech.
Key Takeaways Generac's Q2 sales and earnings estimates imply year-over-year growth of 11% and 18.2%.Data center demand and hyperscale opportunities are expected to power C&I growth in the quarter.Q2 adjusted EBITDA margin is expected near 18%, with faster improvement projected later in 2026. Generac Holdings Inc. (GNRC - Free Report) will report second-quarter 2026 results on July 29, before the market opens.
The Zacks Consensus Estimate for revenues is pinned at $1.18 billion, up 11% from the prior-year reported number. The consensus estimate for earnings is $1.95 per share, up 18.2% year over year. The estimate has remained unchanged in the past 60 days.
GNRC’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, delivering an average surprise of 7.4%.
Price Performance
Image Source: Zacks Investment Research
In the past year, shares of the company have gained 34.1% compared with the Zacks Manufacturing-General Industrial industry’s growth of 3.5%.
Factors at Play Ahead of GNRC’s Q2 ResultsGenerac entered second-quarter 2026 against a backdrop of increasing momentum in its Commercial & Industrial (C&I) segment, driven by robust data center demand, while Residential trends remain more back-half weighted.
Management guided to second-quarter consolidated net sales growth of approximately 9% to 10% year over year, with growth entirely driven by the C&I segment. On the last earnings call, the company highlighted that it was in the final stages of vendor approval with two hyperscale customers. It has also been witnessing backlog expansion for these products with both current and new customers.
Generac’s data center backlog reached more than $700 million at the first quarter-end, representing a roughly $300 million increase since mid-February and providing visibility into 2027 deliveries. Importantly, this number excludes a nonbinding notice to proceed for $600 million in hyperscale data center deliveries expected in 2027, indicating substantial upside potential as the pipeline converts into firm orders. The company has been focused on capacity expansion for large megawatt generators to support accelerating demand.
Within the Residential segment, meaningful growth is skewed toward the second half of 2026, driven by home standby generator, supported by easier comparisons.
Within residential energy technology, ecobee has been emerging as a strategic asset, with more than 5 million connected homes and increased energy services and subscription sales. With the integration of PWRcell 2, PowerMicro microinverter and next-gen standby generators with ecobee, Generac aims to create a differentiated residential energy ecosystem.
Generac expects second-quarter adjusted EBITDA margins to be 18%, representing modest year-over-year expansion. Margin improvement is expected to accelerate in the back half of the year, driven by operating leverage on higher volumes and contributions from the Enercon acquisition.
Nonetheless, volatile macroeconomic conditions, including tariff troubles, stiff competition and increasing operating costs remain additional concerns for Generac.
Heavy reliance on the residential business exposes Generac to weather-driven volatility. Further, data center market expansion brings its own set of concerns. With increasing reliance on this end market, Generac is exposed to cyclical capital spending cycles in AI and data centers. Any delays in manufacturing capacity expansion could also weigh on growth targets.
Also, Residential energy growth in 2025 was largely driven by Puerto Rico’s energy grant-related program. However, with the completion of the program, energy storage systems declined in the first quarter. GNRC is also recalibrating its investments and expects the solar and storage market to contract in 2026 due to reduced U.S. federal incentives.
Key HighlightsOn June 15, 2026, Generac announced an expansion of its packaging capacity for large-megawatt generators through the acquisition of a new facility in Belvidere, IL.
On June 2, 2026, Generac announced a supply agreement with a major hyperscale data center operator to provide backup power generators for its data center infrastructure following a comprehensive qualification and audit process.
What Does Our Model Unveil for GNRC?Our proven model does not predict an earnings beat for Generac this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. This not the case here.
Generac has an Earnings ESP of 0.00% and a Zacks Rank #2 at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to ConsiderHere are a few stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
Celestica (CLS - Free Report) currently has an Earnings ESP of +1.86% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Celestica is scheduled to report quarterly earnings on July 27. The Zacks Consensus Estimate for CLS’ to-be-reported quarter’s earnings and revenues stands at $2.29 per share and $4.35 billion, respectively. Shares of Celestica have gained 96.7% in the past year.
Seagate Technology Holdings plc (STX - Free Report) has an Earnings ESP of +1.75% and a Zacks Rank #1 at present. STX is scheduled to report quarterly figures on July 28. The Zacks Consensus Estimate for Seagate Technology’s to-be-reported quarter’s earnings and revenues is pinned at $5.10 per share and $3.49 billion, respectively. Shares of Seagate Technology are up 505.3% in the past year.
Teradyne (TER - Free Report) has an Earnings ESP of +0.59% and a Zacks Rank #2 at present. The company is scheduled to report quarterly figures on July 28. The Zacks Consensus Estimate for Teradyne’s to-be-reported quarter’s earnings and revenues is pinned at $2.04 per share and $1.22 billion, respectively. Shares of Teradyne are up 314.6% in the past year.
HCA Healthcare ve 2. čtvrtletí zvýšila zředěný zisk na akcii o 11 %, ale kvůli přechodu pacientů z plánů z burz zdravotního pojištění mezi nepojištěné očekává horší celoroční výhled. Nově čeká upravený dopad na EBITDA až -1,2 miliardy USD.
Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitHCA Healthcare NYSE: HCA said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population.
Chief Executive Officer Sam Hazen said the expiration of enhanced premium tax credits at the end of 2025 led more patients to lose exchange coverage than the company had anticipated. While HCA expected some individuals to move to other coverage options, Hazen said patients instead migrated “almost one for one” to uninsured status while continuing to require hospital care.
Get HCA Healthcare alerts:
The Aging of America Could Make HCA Healthcare a Long-Term Winner“The effects, as expected, were that many people became uninsured and still needed emergency care from hospitals,” Hazen said. He added that the impact in the first half of 2026 was greater than the company’s original estimates.
Payer Mix Shift Drives Updated Outlook Same-facility equivalent admissions among patients covered through health insurance exchanges declined 15% in the second quarter and year to date, according to Chief Financial Officer Mike Marks. Equivalent admissions among insured patients excluding exchange plans increased 3.2% in the second quarter, while total uninsured equivalent admissions rose 15%.
This ETF Is Proof That the Healthcare Rebound Is RealMarks said the exchange-related payer mix shift created an approximately $400 million unfavorable impact on adjusted EBITDA in the second quarter. That figure included about $75 million tied to a higher estimate of the first-quarter exchange impact.
The company now expects the full-year adjusted EBITDA impact from health insurance exchange changes to range from negative $1 billion to negative $1.2 billion. Marks said the updated outlook reflects the company’s conclusion that nearly all patients losing exchange coverage are becoming uninsured, compared with its prior assumption that 80% to 85% would do so. HCA also said its original expectation that uninsured patients would use fewer healthcare services did not materialize.
Three divisions—Gulf Coast, North Florida and South Atlantic—accounted for about half of the companywide exchange-related impact. Hazen said exchange adjusted admissions in those divisions declined between 25% and 28% in the first half.
HCA revised its full-year 2026 guidance to:
Revenue of $77 billion to $79.5 billion. Adjusted EBITDA of $15.4 billion to $16.1 billion. Net income attributable to HCA Healthcare of $6.3 billion to $6.7 billion. Diluted earnings per share of $28.70 to $30.50. Marks said the revised outlook is more consistent with HCA’s long-term adjusted EBITDA growth target of 4% to 6%, following moderation from the company’s 2025 growth rate and its initial 2026 assumptions.
Medicaid Programs Offset Pressure in the Quarter The company recognized approximately $400 million of incremental net benefit from Medicaid supplemental payment programs during the second quarter. That included a $540 million incremental net benefit related to a recently approved Florida program covering the period from Oct. 1, 2024, through June 30, 2026, or 21 months.
The Florida benefit was partly offset by retroactive payments received in the second quarter of 2025. HCA’s annual guidance assumes a net Medicaid supplemental-payment benefit of $300 million to $500 million, but Marks said the outlook implies a $100 million to $300 million headwind in the second half because prior program approvals and retroactive payments are expected to exceed the incremental benefit from the Florida program.
Hazen described Medicaid supplemental programs as important to supporting access to care for Medicaid patients, particularly as hospitals provide more uncompensated care to uninsured patients.
Demand Growth Continues, Though Surgeries Decline Same-facility admissions increased 2.5% in the second quarter, while equivalent admissions rose 2.7%. Emergency room visits increased 3.6%, with cardiac procedures and rehabilitation volumes also contributing to demand.
However, inpatient surgeries declined 2.3% and outpatient surgeries fell 3.4%. Hazen attributed much of the decline to reduced demand for elective procedures, including patients previously covered through exchange plans. He also cited physician feedback regarding affordability pressures affecting patients and the effect of Medicare inpatient rule changes that have shifted some cases from inpatient to outpatient settings.
Emergency inpatient surgeries, which account for about two-thirds of HCA’s inpatient surgical cases, increased 2% year over year through the first six months. By contrast, elective inpatient surgeries were down 6% this year, compared with a 2% decline in the prior year.
Despite the surgical weakness, Hazen said the company remains encouraged by demand and continues to expect long-term demand growth of 2% to 3%, supported by population growth and market trends in its communities.
Capital Investment and Cost Initiatives HCA has approved more than $7 billion of capital spending expected to come online over the next three years. The investments include 1,000 to 1,200 additional inpatient beds, new hospitals in certain markets, and additional outpatient facilities.
Hazen said the company had approximately 42,000 beds currently in operation, up from roughly 37,000 at the end of 2018. Occupancy increased to 75% from 71% over that period. HCA also had 5% more outpatient sites of care in the second quarter than a year earlier and expects another 250 to 300 outpatient facilities in its capital or acquisition pipeline to open later this year or early next year.
The company spent $1.2 billion on capital expenditures during the quarter, repurchased $2.1 billion of shares and paid $171 million in dividends. Cash flow from operations was $2.3 billion, down 45% year over year, primarily because of the timing of Florida Medicaid supplemental-payment cash flows and the prior-year deferral of federal income tax payments.
HCA maintained its planned 2026 capital expenditure range of $5 billion to $5.5 billion and said it currently expects to complete most of its existing share-repurchase authorization, subject to market conditions and other factors.
On costs, Marks said same-facility cost per equivalent admission, including the effect of Medicaid supplemental payment programs, was essentially flat from a year earlier and improved 1.4% sequentially. He said HCA’s financial resiliency program—which includes digital transformation, global capabilities and expanded shared services—is intended to produce multiyear efficiency benefits. Professional fees remained elevated, rising about 8.5% year over year in the quarter, primarily due to anesthesia and radiology costs.
About HCA Healthcare (NYSE:HCA)HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in HCA Healthcare Right Now?Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Unum Group čeká za 2. čtvrtletí růst zisku na 2,14 USD na akcii, ale tržby mají klesnout na 2,95 miliardy USD. Tahounem mají být lepší prodeje a persistency, zatímco náklady porostou.
Key Takeaways Unum is expected to benefit from favorable persistency and stronger sales across its insurance businesses. UNM's key operating segments are likely to see growth from voluntary benefits, life and disability products. Unum is expected to face higher expenses, while continued share buybacks may support earnings. Unum Group (UNM - Free Report) is expected to register an improvement in its bottom line but a decline in the top line when it reports second-quarter 2026 results on July 28, after the closing bell.
The Zacks Consensus Estimate for UNM’s second-quarter revenues is pegged at $2.95 billion, indicating a 12.6% decline from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.14 per share. The Zacks Consensus Estimate for UNM’s second-quarter earnings has moved south by 0.4% in the past 30 days. The estimate suggests a year-over-year increase of 3.3%.
What the Zacks Model Unveils for UNMOur proven model does not conclusively predict an earnings beat for Unum Group this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold). This is not the case, as you can see below:
Earnings ESP: Unum Group has an Earnings ESP of -0.89%. This is because the Most Accurate Estimate of $2.13 is pegged lower than the Zacks Consensus Estimate of $2.14. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: Unum Group currently carries a Zacks Rank #3.
Factors Likely to Shape Q2 Results of UNMFavorable persistency and better sales in the operating segments are likely to have favored premiums in the second quarter. Our estimate and the Zacks Consensus Estimate for premium income are both pegged at $2.6 billion.
Net investment income is likely to have increased due to higher invested assets and higher miscellaneous investment income. Our estimate for investment income is pegged at $297.3 million, suggesting a 47% decrease from the year-ago quarter. The Zacks Consensus Estimate is pegged at $269 million.
The performance of Unum U.S. and Colonial Life — two of the largest operating segments — is likely to have been driven by stable overall persistency in the voluntary benefits and dental and vision product lines, and higher prior period sales in the voluntary benefits product line, improved benefit experience across life, accident, sickness, and disability product lines, and in-force block growth.
Better performance in life and group disability is likely to aid Unum U.S. results.
Our estimate for Unum U.S. operating revenues is pegged at $2 billion, while the same for Colonial Life is pinned at $516.5 million.
Favorable results at group long-term disability, Group Life and Supplemental are likely to have favored Unum UK. This, combined with in-force block growth, sales and favorable overall persistency at Unum Poland, is likely to have benefited Unum International. Our estimate for Unum International’s operating revenues is pegged at $336.1 million.
Expenses are likely to have increased because of higher policy benefits, commissions, interest and debt expense, amortization of deferred acquisition costs and other expenses.
Continued share buybacks are likely to have contributed to the bottom line.
Stocks to ConsiderSome insurance stocks with the right combination of elements to deliver an earnings beat this time around are:
Aflac Incorporated (AFL - Free Report) has an Earnings ESP of +0.34% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 0.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.
AFL’s earnings beat estimates in two of the last four reported quarters and missed in the other two.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +2.59% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $5.61, indicating a year-over-year decrease of 5.5%.
ALL’s earnings beat estimates in each of the last four reported quarters.
Axis Capital Holdings Limited (AXS - Free Report) has an Earnings ESP of +3.82% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.23, indicating a year-over-year decrease of 1.8%.
AXS’s earnings beat estimates in each of the last four reported quarters.
IQVIA čeká ve 2. čtvrtletí tržby 4,3 miliardy USD, tedy meziroční růst o 6,7 %, a EPS 3,02 USD. Růst má podpořit AI, nová uvedení léků na trh a adopce Data-as-a-Service.
Key Takeaways IQVIA's Q2 revenues are expected to rise 6.7% y/y to $4.3 billion, with EPS at $3.02.Commercial solutions growth is expected from drug launches, AI demand and Data-as-a-Service adoption.AI-led workflow gains and backlog conversion are expected to support research and development solutions. IQVIA Holdings Inc. (IQV - Free Report) is set to release second-quarter 2026 results on July 28, before market open.
IQV has a decent earnings surprise history, having surpassed the Zacks Consensus Estimate in the trailing four quarters, with an average surprise of 1.6%.
IQVIA’s Q2 ExpectationsThe Zacks Consensus Estimate for revenues is pegged at $4.3 billion, implying 6.7% year-over-year growth. Growth in the top line is likely to have been stimulated by an efficient use of AI across its business lines.
Revenue gains in the commercial solutions segment are expected to have emanated extensively from rising drug launch activity. Surging demand for the company’s exclusive AI capabilities, tailored AI agents and AI-ready data foundations is anticipated to have added to the growth trajectory.
We expect the rapid adoption of Data-as-a-Service, resulting in multi-year client agreements and enterprise-wide platform adoptions, enhancing commercial intelligence and analytics, to have acted as a major catalyst to this segment’s growth.
For the research and development solutions segment, we expect IQVIA to have leveraged AI to optimize workflow, accelerate study execution and cut down errors, thus improving its revenues. Scheduled conversion of contracted backlogs into revenues over the upcoming months is likely to have contributed to the segment’s growth.
The consensus estimate for earnings per share is $3.02, implying 7.5% year-over-year growth. Enhancement in operational prowess springing from high-margin revenue growth across segments is anticipated to have benefited the bottom line.
What Our Model Says About IQVOur proven model does not conclusively predict an earnings beat for IQVIA this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
IQV has an Earnings ESP of -2.98% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are a few stocks from the broader Medical sector, which, according to our model, have the right combination of elements to beat on earnings this time around.
Alcon (ALC - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2026 revenues is pegged at $2.8 billion, indicating 7.3% year-over-year growth. For earnings, the consensus mark is pinned at 77 cents per share, moving up 1.3% from the year-ago quarter’s reported figure. The company beat the consensus estimate in three of the past four quarters and missed once, with an average surprise of 3.7%.
ALC carries an Earnings ESP of +3.13% and a Zacks Rank of 3 at present. The company is scheduled to declare second-quarter 2026 results on Aug. 10.
Waters (WAT - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2026 revenues is pinned at $1.6 billion, hinting at 3% year-over-year growth. For earnings, the consensus mark is pinned at $3.01 per share, improving 2% from the year-ago quarter’s reported figure. WAT beat the consensus estimate for earnings in the trailing four quarters, with an average surprise of 6%.
WAT has an Earnings ESP of +0.45% and a Zacks Rank of 3 at present. The company is scheduled to declare second-quarter 2026 results on Aug. 4.
Liquidia hlásí, že Yutrepia od spuštění v červnu 2025 táhne růst: ve 1. čtvrtletí 2026 přinesla asi 130 milionů USD tržeb a firma vykázala třetí ziskové čtvrtletí v řadě.
Key Takeaways Liquidia's Yutrepia launch has driven strong sales, adoption and three straight profitable quarters. LQDA projects far faster 2026 revenue and EPS growth, backed by rising earnings estimates.United Therapeutics counters with a broad PAH portfolio and late-stage ralinepag pipeline. Liquidia Corporation (LQDA - Free Report) is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
United Therapeutics (UTHR - Free Report) boasts six FDA-approved therapies that treat PAH, PH-ILD, and neuroblastoma, a rare pediatric cancer, in its portfolio.
Liquidia and United Therapeutics are locked in a fierce battle in the PAH market, with Liquidia's Yutrepia emerging as a challenger to United Therapeutics' blockbuster Tyvaso franchise. Their competition extends beyond commercial sales to patent disputes and a race to capture a larger share of the inhaled treprostinil market.
Given this backdrop, selecting one stock over the other can be difficult. We therefore evaluate their fundamentals, growth prospects, challenges and valuation metrics to help make an informed decision.
The Case for LQDALiquidia currently markets Yutrepia (treprostinil) inhalation powder, approved by the FDA in May 2025 and launched the following month commercially.
The company also generates revenues through a profit-sharing agreement with Sandoz for the promotion of its generic treprostinil injection in the United States.
Yutrepia is an inhaled dry-powder formulation of treprostinil developed using Liquidia's proprietary PRINT particle engineering technology. The platform is designed to enhance deep lung drug delivery, simplify administration through a low-effort dry-powder inhaler and enable higher dose levels than currently marketed inhaled treprostinil therapies.
The company supports commercialization through a specialized sales force focused on physicians treating PAH and PH-ILD, as well as stakeholders involved in reimbursement and drug distribution.
Since its launch in June 2025, Yutrepia has emerged as a strong growth driver, generating approximately $130 million in first-quarter 2026 sales. The therapy has demonstrated robust adoption, with more than 4,500 unique prescriptions, around 3,750 patients initiating treatment, and nearly 1,000 physicians prescribing the drug.
Its rapid uptake helped Liquidia post its third consecutive profitable quarter, highlighting Yutrepia's growing commercial success.
Beyond its commercial portfolio, Liquidia is advancing a pipeline of therapies for pulmonary vascular diseases. Its lead pipeline candidate, L606, is an investigational liposomal formulation of treprostinil administered twice daily via a next-generation nebulizer. L606 is being evaluated in an open-label study for PAH and PH-ILD, while a global pivotal placebo-controlled trial is underway in PH-ILD.
Liquidia also plans to expand Yutrepia into additional indications, including pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF) and Raynaud's phenomenon associated with systemic sclerosis.
The Case for UTHRUnited Therapeutics markets a broad PAH portfolio led by Tyvaso DPI, a dry-powder inhaled formulation of the prostacyclin analogue treprostinil, which was approved by FDA in May 2022 to improve exercise ability in patients with PAH and PH-ILD.
Its portfolio includes nebulized Tyvaso, a nebulized liquid inhaled formulation of treprostinil, approved by the FDA to improve exercise ability in patients with PAH and PH-ILD.
The company also markets Remodulin, a continuously infused treprostinil therapy for PAH administered subcutaneously or intravenously, supported by the user-friendly RemunityPRO infusion pump. Its PAH portfolio further includes Orenitram, an oral extended-release treprostinil tablet, and Adcirca (tadalafil), an oral PDE-5 inhibitor licensed from Eli Lilly through the end of 2026.
Sales of Tyvaso products continue to grow, driven by higher volumes and continued growth in commercialization utilization. Moreover, Orenitram offers a convenient oral treatment option that avoids the challenges associated with continuous infusion therapies, such as Remodulin, and inhaled therapies requiring multiple daily administrations.
The company remains focused on developing additional therapies for PAH and pulmonary fibrosis (PF).
Ralinepag, an investigational, highly selective and potent prostacyclin (IP) receptor, is one of United Therapeutics' most promising late-stage pipeline assets. The candidate is being developed in two formulations — an oral version and a DPI version (RAL-DPI).
Based on positive data from the pivotal phase III ADVANCE OUTCOMES study, United Therapeutics intends to submit a new drug application for ralinepag (to treat PAH) to the FDA by the second half of 2026.
If approved, oral ralinepag could strengthen United Therapeutics’ leadership in PAH and potentially offset future competitive pressure on older products.
Beyond the oral formulation, United Therapeutics is also developing inhaled dry-powder versions of ralinepag, RAL-DPI, in collaboration with MannKind Corporation. While initially targeting PAH, management sees opportunities for RAL-DPI in PH-ILD, IPF and PPF. Together, the oral and inhaled formulations position ralinepag as a potential cornerstone of United Therapeutics' future growth strategy.
Outside its PAH franchise, the company markets Unituxin for the treatment of high-risk neuroblastoma.
UTHR strengthened its long-term regenerative medicine strategy by acquiring preclinical stage biotech Thymmune Therapeutics for $140 million upfront, with up to $160 million in milestone payments. The deal adds THY-100, a stem cell-derived thymic cell therapy being developed for congenital athymia, and a platform with potential applications in organ transplantation, autoimmune diseases and immune deficiencies. The acquisition broadens United Therapeutics' pipeline beyond PAH.
A Look at Estimates: LQDA versus UTHRThe Zacks Consensus Estimate for LQDA’s 2026 sales implies a year-over-year increase of 315.77%, while that for earnings per share (EPS) suggests a year-over-year improvement of 477.5%. The Zacks Consensus Estimate for 2026 EPS has moved north to $3.02 from $2.97 and that for 2027 EPS has increased to $4.92 from $4.81 in the past 60 days.
LQDA’s Estimate Movement
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UTHR’s 2026 sales implies a year-over-year increase of 1.46%, while that for EPS suggests a year-over-year decline of 4.41%. EPS estimates for 2026 have moved south to $26.63 in the past 60 days but those for 2026 have moved north to $31.66 from $31.09 during the said time frame.
UTHR’s Estimate Movement
Image Source: Zacks Investment Research
Price Performance and Valuation of LQDA and UTHRFrom a price-performance perspective, LQDA has fetched better returns than UTHR so far in the year. Shares of LQDA have surged 158.2%, while those of UTHR have gained 8.7%. The industry has gained 1.4% in the said period.
Image Source: Zacks Investment Research
From a valuation standpoint, LQDA is more expensive than UTHR. LQDA’s shares currently trade at 8.74X forward sales, higher than 6.50X for UTHR.
Image Source: Zacks Investment Research
Which Stock Is a Better Pick for Now?LQDA currently sports a Zacks Rank #1 (Strong Buy), while UTHR carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Although United Therapeutics remains the established leader in PAH with a diversified portfolio, a robust late-stage pipeline and expansion into regenerative medicine, much of its growth appears incremental.
In contrast, Liquidia is in the early stages of a rapid commercial expansion, driven by the impressive launch of Yutrepia, expanding label opportunities and a promising pipeline. The company's superior revenue and earnings growth outlook, upward estimate revisions, stronger year-to-date share price performance and better Zacks Rank outweigh its premium valuation.
While UTHR remains a solid long-term holding, Liquidia offers the more compelling growth story and greater upside potential at current levels, making LQDA the better pick for investors seeking higher returns.
First Hawaiian oznámila ve 2. čtvrtletí růst úvěrů o 137 milionů USD a vyšší čistou úrokovou marži na 3,25 %. Zároveň se připravuje na plánované spojení s TriCo Bancshares.
First Hawaiian NASDAQ: FHB executives said the bank delivered loan growth, wider net interest margin and continued solid credit quality in the second quarter of 2026, while preparing for its proposed combination with TriCo Bancshares.
Chairman, President and CEO Bob Harrison said the company was “very excited” about the TriCo transaction, which is expected to close near the end of the year. He said First Hawaiian is focused on the work required to complete the deal and does not have additional information beyond what was presented during its July 23 investor call.
Get First Hawaiian alerts:
Hawaii economy and loan growth Harrison pointed to relatively stable economic conditions in Hawaii. The statewide employment rate was 2.5% in May, compared with a national unemployment rate of 4.3%. Total visitor arrivals through May rose 2.9% from a year earlier, driven primarily by visitors from the U.S. mainland and Japan, while year-to-date visitor spending reached $9.7 billion, up 7.5% from 2025 levels.
Hawaii housing prices also remained firm. The median Oahu single-family home sales price was $1.2 million in June, up 10.4% year over year, while the median condo price was $528,000, up 3.5%.
Total loans increased $137 million during the quarter, representing annualized growth of about 3.6%. Growth was led by commercial and industrial, or C&I, lending and commercial real estate lending. C&I balances increased $98 million, primarily because of dealer-flooring growth and expansion in the company’s Hawaii corporate portfolio.
Completed construction projects resulted in the conversion of $95 million in construction loan balances into commercial real estate loans. Construction loan payoffs and lower residential balances partly offset the broader growth, as residential payoffs exceeded new production.
Harrison said management continues to see a “very robust pipeline” in C&I and commercial real estate, with construction activity representing a meaningful portion of commercial real estate opportunities. The bank also is working with some new customer relationships, he said. Residential lending, however, is expected to remain slow because of the interest-rate environment.
Deposits, margin and earnings outlook Total deposits declined $623 million in the second quarter, largely due to expected public-deposit outflows. Chief Financial Officer Jamie Moses said retail deposits were essentially flat, while commercial deposits fell about $156 million because of seasonal volatility. Public deposits declined $467 million, mainly in operating accounts, and public time deposits decreased by $115 million. The remaining public time-deposit balance was $9 million.
Moses said the declines did not reflect lost customer relationships. Municipal partners found other ways to invest certain balances off the bank’s balance sheet, he said, while First Hawaiian expects retail and commercial deposits to increase in the second half because of seasonal patterns. The company’s noninterest-bearing deposit ratio was 32%, and its total cost of deposits declined two basis points from the first quarter.
Net interest income increased $3.5 million sequentially to $171 million. Net interest margin rose six basis points to 3.25%, helped by deposit mix and repricing, higher loan and securities yields, and lower cash balances.
Management revised its full-year net interest margin outlook to a range of 3.24% to 3.25%, based on market expectations for one rate increase later this year. First Hawaiian expects third-quarter margin of about 3.27%. Moses said the company assumed a rate increase early in the fourth quarter in its outlook.
The balance sheet remains asset-sensitive, according to Harrison. Moses said roughly $6 billion of assets would reprice immediately following a rate increase based on SOFR, while approximately $3.5 billion to $4 billion of liabilities would also reprice to some degree.
Cash balances declined in the quarter primarily because of public-deposit outflows. Management expects to keep cash around the quarter-end level, approximately $1 billion, through the rest of the year, even as it anticipates further loan growth.
Fees, expenses and credit quality Noninterest income totaled $60.3 million, aided by higher bank-owned life insurance income, an excise tax refund and increased swap fees. Moses said the BOLI contribution reflected a component of the portfolio that is sensitive to market movements rather than a death benefit.
First Hawaiian maintained its full-year noninterest income outlook of about $220 million. Moses said the company generally views approximately $55 million per quarter as a baseline, though one-time or market-related items can cause quarterly variation.
Noninterest expense was $130.4 million, including $4.2 million in costs related to the TriCo transaction. The company expects more transaction costs in the second half as it moves toward closing and integration. Excluding TriCo-related costs, First Hawaiian expects reported expenses of $515 million to $520 million for the full year.
Moses said higher second-half expenses will reflect continued hiring to support loan growth, along with project-related salary, professional-services and information-technology costs.
Chief Risk Officer Lea Nakamura said credit performance and credit metrics remained healthy. The allowance for credit losses declined both in dollar terms and relative to coverage, primarily because of a material reduction in classified assets.
The company reported a return on average tangible assets of 1.28% and a return on average tangible equity of 16.34% for the quarter. Its effective tax rate was 22.9%.
TriCo transaction and capital plans Harrison said First Hawaiian did not repurchase shares during the second quarter and is unlikely to conduct buybacks for the remainder of the year while the TriCo deal proceeds through regulatory review, though he said that could change. The company’s common equity tier 1 ratio remained above 13%, according to an analyst’s question during the call.
Management reiterated a target of 25% cost savings from the TriCo transaction. Moses said the company remains comfortable with that objective and expects to achieve it through a variety of measures, but did not provide further detail.
Harrison said three TriCo executives—Richard Smith, Dan Bailey and Peter G. Wiese—are expected to join First Hawaiian’s senior management team. He said First Hawaiian intends to retain much of TriCo’s management team, describing the California bank as a well-run institution that First Hawaiian plans to support while learning from its operations.
About First Hawaiian (NASDAQ:FHB)First Hawaiian, Inc is the oldest and largest bank in Hawaii, operating as the bank holding company for First Hawaiian Bank. Established in 1858, the company offers a full suite of financial services to individual, business and institutional clients. Its product portfolio includes consumer and commercial lending, deposit accounts, treasury and cash management, foreign exchange and trade finance, as well as wealth management and trust services.
First Hawaiian serves customers through an extensive network of branches, ATMs and digital channels across the Hawaiian Islands, Guam, Saipan and American Samoa.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in First Hawaiian Right Now?Before you consider First Hawaiian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Hawaiian wasn't on the list.
While First Hawaiian currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
SouthState Bank ve 2. čtvrtletí uvedla meziroční růst úvěrů o 8 % a stabilní čistou úrokovou marži 3,78 %. Čisté odpisy z úvěrů činily 6 bazických bodů a problémová aktiva klesla o 14 %.
SouthState Bank NYSE: SSB reported second-quarter 2026 results marked by continued loan growth, stable net interest margin, low credit losses and ongoing investment in banker recruiting and artificial intelligence initiatives.
Chief Executive Officer John Corbett said the company generated a 1.36% return on assets and a 17.6% return on tangible common equity during the quarter. He said results reflected “solid balance sheet growth, stable margins, improving efficiency, and continued strength in credit quality.”
Over the past year, loans increased 8% and deposits rose 5%, both within the company’s previously issued guidance ranges. During the second quarter, loan growth totaled $1.35 billion, representing an 11% annualized rate. Average loan growth also ran at an 11% annualized pace.
Get SouthState Bank alerts:
Corbett said growth was broad-based across SouthState’s footprint, with Florida leading the company in loan-growth dollars. Florida, Texas and South Carolina were the largest contributors by dollar amount, while Atlanta, Virginia and Alabama posted strong percentage growth, including commercial and industrial lending gains in Atlanta.
Recruiting Supports Growth Strategy SouthState has expanded its commercial banking sales force by more than 10% over the past three quarters as it seeks to capitalize on disruption in its markets. Corbett said the company had offered division presidents the opportunity to increase their commercial relationship manager teams by 15% to 20% over several years.
The newer hires have generated $600 million of loan production so far and have a $1.5 billion pipeline, according to Corbett. Texas has been the strongest market for sales-force expansion, with its commercial relationship manager count up 25%.
The company expects loan growth to remain in the mid- to upper-single-digit range. Corbett said SouthState sees a potential mix shift in the second half, with commercial and industrial lending expected to increase while planned commercial real estate payoffs, including multifamily projects, rise.
Construction lending increased during the quarter, driven partly by owner-occupied projects for commercial clients and multifamily construction. However, Corbett noted that the overall construction category remained about 10% below its level a year earlier.
Margin Outlook Remains Stable SouthState reported a net interest margin of 3.78%, down 1 basis point from the first quarter and within its 3.75% to 3.80% guidance range. Deposit costs were unchanged from the prior quarter at 1.76%, while loan yields declined 5 basis points to 5.91% due to lower purchase-accounting accretion income.
Excluding accretion, loan yields increased 1 basis point and net interest margin rose 4 basis points, the company said. Net interest income totaled $576 million, up $14 million from the first quarter.
Chief Strategy Officer Steve Young said management’s outlook assumes no interest-rate increases or reductions through 2027 and calls for net interest margin to remain within the 3.75% to 3.80% range. He said deposit costs could rise modestly as the company funds loan growth, but anticipated asset repricing should help support the margin.
SouthState said approximately 76% of quarterly loan production carried floating rates. The share of the overall loan portfolio in floating-rate loans has increased to 38%, from 32% a year earlier.
Management also pointed to future repricing opportunities, including roughly $6 billion of loans expected to reprice over the next year and about $1 billion of securities expected to cash flow and be reinvested. Young said legacy loans with coupons in the 3% to 4% range are being replaced at rates in the 6% range.
Credit Quality and Expenses Credit quality improved during the quarter. Nonperforming assets declined 14%, classified loans also decreased, and net charge-offs were 6 basis points. It was the eighth time in the past nine quarters that SouthState’s net charge-offs were below 10 basis points.
Provision expense was $16 million, primarily reflecting loan growth. Management said it expects modest downward pressure on reserve levels absent meaningful changes in Moody’s economic forecasts and other loss drivers. The company continues to use a more conservative weighting toward Moody’s pessimistic scenario than its traditional model weighting.
Noninterest income was $97 million, or 57 basis points of average assets, within the company’s 55- to 60-basis-point guidance range. The figure was $3 million below the first quarter, as higher deposit fees were offset by lower mortgage revenue. SouthState said it continues to expect correspondent banking revenue of roughly $25 million per quarter.
Noninterest expense totaled $358 million, slightly better than guidance. Management maintained its forecast for 4% noninterest expense growth in 2026. It expects compensation costs to rise in the second half as recently hired employees remain in the run rate and company merit increases take effect July 1.
Capital Returns and Technology Investment SouthState repurchased 1 million shares during the quarter at a weighted average price of $97.62, producing a 68% total payout ratio including dividends. Year-to-date repurchases totaled 2.5 million shares and the total payout ratio was 80%.
Corbett said the company repurchased nearly 5% of its outstanding shares over the past year while increasing its dividend and maintaining a common equity tier 1 capital ratio above 11%. CET1 ended the quarter at 11.1%, tangible common equity was 8.7%, and tangible book value per share was $58.72, up 13% from a year earlier.
Management reiterated its longer-term total capital return framework of 40% to 60%, saying recent higher repurchase activity is not expected to be sustained if the company continues to target mid- to high-single-digit loan growth while maintaining CET1 in an 11% to 12% range.
Corbett also highlighted artificial intelligence as a strategic priority. The company is using the technology in credit operations, fraud management and call-center support, as well as through an internally developed small language model. SouthState is also testing commodity-hedging and foreign-exchange offerings, though Young said those initiatives are expected to launch in 2027 rather than materially affect 2026 results.
About SouthState Bank (NYSE:SSB)SouthState Bank NYSE: SSB is a bank holding company headquartered in Winter Haven, Florida, that provides a range of commercial and retail banking services. Through its subsidiary, SouthState Bank, the company serves businesses, institutions and individuals with deposit, lending and treasury management solutions. Its core business lines include commercial and industrial loans, commercial real estate lending, consumer mortgages and home equity loans.
In addition to traditional lending and deposit products, SouthState Bank offers specialized services such as treasury and cash management, merchant services, payment solutions and online banking.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in SouthState Bank Right Now?Before you consider SouthState Bank, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SouthState Bank wasn't on the list.
While SouthState Bank currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
